<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:55:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8718087" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8718087</identifier>
        <datestamp>2022-01-07</datestamp>
        <setSpec>cachex</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jcsm12815" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Cachexia Sarcopenia Muscle</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Cachexia Sarcopenia Muscle</journal-id>
              <journal-id journal-id-type="doi">10.1007/13539.2190-6009</journal-id>
              <journal-id journal-id-type="publisher-id">JCSM</journal-id>
              <journal-title-group>
                <journal-title>Journal of Cachexia, Sarcopenia and Muscle</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2190-5991</issn>
              <issn pub-type="epub">2190-6009</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8718087</article-id>
              <article-id pub-id-type="pmcid">PMC8718087</article-id>
              <article-id pub-id-type="pmc-uid">8718087</article-id>
              <article-id pub-id-type="pmid">34666419</article-id>
              <article-id pub-id-type="pmid">34666419</article-id>
              <article-id pub-id-type="doi">10.1002/jcsm.12815</article-id>
              <article-id pub-id-type="publisher-id">JCSM12815</article-id>
              <article-id pub-id-type="other">JCSM-D-21-00081</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A randomized clinical trial on the effects of exercise on muscle remodelling following bariatric surgery</article-title>
                <alt-title alt-title-type="right-running-head">Exercise, bariatric surgery, and skeletal muscle</alt-title>
                <alt-title alt-title-type="left-running-head">S. Gil <italic toggle="yes">et al</italic>.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jcsm12815-cr-0001" contrib-type="author">
                  <name>
                    <surname>Gil</surname>
                    <given-names>Saulo</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0002" contrib-type="author">
                  <name>
                    <surname>Kirwan</surname>
                    <given-names>John P.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0003" contrib-type="author">
                  <name>
                    <surname>Murai</surname>
                    <given-names>Igor H.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0004" contrib-type="author">
                  <name>
                    <surname>Dantas</surname>
                    <given-names>Wagner S.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0005" contrib-type="author">
                  <name>
                    <surname>Merege‐Filho</surname>
                    <given-names>Carlos Alberto Abujabra</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0006" contrib-type="author">
                  <name>
                    <surname>Ghosh</surname>
                    <given-names>Sujoy</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0007" contrib-type="author">
                  <name>
                    <surname>Shinjo</surname>
                    <given-names>Samuel K.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0008" contrib-type="author">
                  <name>
                    <surname>Pereira</surname>
                    <given-names>Rosa M.R.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0009" contrib-type="author">
                  <name>
                    <surname>Teodoro</surname>
                    <given-names>Walcy R.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0010" contrib-type="author">
                  <name>
                    <surname>Felau</surname>
                    <given-names>Sheylla M.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0011" contrib-type="author">
                  <name>
                    <surname>Benatti</surname>
                    <given-names>Fabiana B.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0012" contrib-type="author">
                  <name>
                    <surname>de Sá‐Pinto</surname>
                    <given-names>Ana L.</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0013" contrib-type="author">
                  <name>
                    <surname>Lima</surname>
                    <given-names>Fernanda</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0014" contrib-type="author">
                  <name>
                    <surname>de Cleva</surname>
                    <given-names>Roberto</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0015" contrib-type="author">
                  <name>
                    <surname>Santo</surname>
                    <given-names>Marco Aurélio</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0016" contrib-type="author">
                  <name>
                    <surname>Gualano</surname>
                    <given-names>Bruno</given-names>
                  </name>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jcsm12815-cr-0017" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Roschel</surname>
                    <given-names>Hamilton</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9513-6132</contrib-id>
                  <xref rid="jcsm12815-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jcsm12815-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <address>
                    <email>hars@usp.br</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jcsm12815-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Applied Physiology &amp; Nutrition Research Group, School of Physical Education and Sport, Rheumatology Division, Faculdade de Medicina FMUSP</named-content>
                <institution>Universidade de São Paulo</institution>
                <city>São Paulo</city>
                <named-content content-type="country-part">SP</named-content>
                <country country="BR">Brazil</country>
              </aff>
              <aff id="jcsm12815-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Laboratory of Assessment and Conditioning in Rheumatology</named-content>
                <institution>Universidade de São Paulo</institution>
                <city>São Paulo</city>
                <named-content content-type="country-part">SP</named-content>
                <country country="BR">Brazil</country>
              </aff>
              <aff id="jcsm12815-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina</named-content>
                <institution>Universidade de São Paulo</institution>
                <city>São Paulo</city>
                <country country="BR">Brazil</country>
              </aff>
              <aff id="jcsm12815-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center</named-content>
                <institution>Louisiana State University</institution>
                <city>Baton Rouge</city>
                <named-content content-type="country-part">LA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jcsm12815-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Laboratory of Computational Biology, Pennington Biomedical Research Center</named-content>
                <institution>Louisiana State University</institution>
                <city>Baton Rouge</city>
                <named-content content-type="country-part">LA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jcsm12815-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Centre for Computational Biology</named-content>
                <institution>Duke‐NUS Medical School</institution>
                <country country="SG">Singapore</country>
              </aff>
              <aff id="jcsm12815-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">School of Applied Sciences</named-content>
                <institution>Universidade Estadual de Campinas</institution>
                <city>São Paulo</city>
                <country country="BR">Brazil</country>
              </aff>
              <aff id="jcsm12815-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">Gastroenterology Department, Digestive Surgery Division Department of Digestive Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina</named-content>
                <institution>Universidade de São Paulo</institution>
                <city>São Paulo</city>
                <country country="BR">Brazil</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Correspondence to: Hamilton Roschel, Applied Physiology &amp; Nutrition Research Group, School of Physical Education and Sport, Rheumatology Division, Faculdade de Medicina FMUSP, Universidade de São Paulo, Av. Dr. Arnaldo, 455‐Pacaembu, São Paulo, SP, Brazil. Email: <email>hars@usp.br</email>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>19</day>
                <month>10</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>12</month>
                <year>2021</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="90">6</issue>
              <issue-id pub-id-type="doi">10.1002/jcsm.v12.6</issue-id>
              <fpage>1440</fpage>
              <lpage>1455</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>27</day>
                  <month>7</month>
                  <year>2021</year>
                </date>
                <date date-type="received">
                  <day>12</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>07</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders-->
                <copyright-statement content-type="article-copyright">© 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley &amp; Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JCSM-12-1440.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="jcsm12815-sec-0001">
                  <title>Background</title>
                  <p>Muscle atrophy and strength loss are common adverse outcomes following bariatric surgery. This randomized, controlled trial investigated the effects of exercise training on bariatric surgery‐induced loss of muscle mass and function. Additionally, we investigated the effects of the intervention on molecular and histological mediators of muscle remodelling.</p>
                </sec>
                <sec id="jcsm12815-sec-0002">
                  <title>Methods</title>
                  <p>Eighty women with obesity were randomly assigned to a Roux‐en‐Y gastric bypass (RYGB: <italic toggle="yes">n</italic> = 40, age = 42 ± 8 years) or RYGB plus exercise training group (RYGB + ET: <italic toggle="yes">n</italic> = 40, age = 38 ± 7 years). Clinical and laboratory parameters were assessed at baseline, and 3 (POST3) and 9 months (POST9) after surgery. The 6 month, three‐times‐a‐week, exercise intervention (resistance plus aerobic exercise) was initiated 3 months post‐surgery (for RYGB + ET). A healthy, lean, age‐matched control group was recruited to provide reference values for selected variables.</p>
                </sec>
                <sec id="jcsm12815-sec-0003">
                  <title>Results</title>
                  <p>Surgery resulted in a similar (<italic toggle="yes">P</italic> = 0.66) reduction in lower‐limb muscle strength in RYGB and RYGB+ET (−26% vs. −31%), which was rescued to baseline values in RYGB + ET (<italic toggle="yes">P</italic> = 0.21 vs. baseline) but not in RYGB (<italic toggle="yes">P</italic> &lt; 0.01 vs. baseline). Patients in RYGB+ET had greater absolute (214 vs. 120 kg, <italic toggle="yes">P</italic> &lt; 0.01) and relative (2.4 vs. 1.4 kg/body mass, <italic toggle="yes">P</italic> &lt; 0.01) muscle strength compared with RYGB alone at POST9. Exercise resulted in better performance in timed‐up‐and‐go (6.3 vs. 7.1 s, <italic toggle="yes">P</italic> = 0.05) and timed‐stand‐test (18 vs. 14 repetitions, <italic toggle="yes">P</italic> &lt; 0.01) compared with RYGB. Fat‐free mass was lower (POST9‐PRE) after RYBG than RYGB + ET (total: −7.9 vs. −4.9 kg, <italic toggle="yes">P</italic> &lt; 0.01; lower‐limb: −3.8 vs. −2.7 kg, <italic toggle="yes">P</italic> = 0.02). Surgery reduced Types I (~ − 21%; <italic toggle="yes">P</italic> = 0.99 between‐group comparison) and II fibre cross‐sectional areas (~ − 27%; <italic toggle="yes">P</italic> = 0.88 between‐group comparison), which were rescued to baseline values in RYGB+ET (<italic toggle="yes">P</italic> &gt; 0.05 vs. baseline) but not RYGB (<italic toggle="yes">P</italic> &gt; 0.01 vs. baseline). RYGB + ET showed greater Type I (5187 vs. 3898 μm<sup>2</sup>, <italic toggle="yes">P</italic> &lt; 0.01) and Type II (5165 vs. 3565 μm<sup>2</sup>, <italic toggle="yes">P</italic> &lt; 0.01) fCSA than RYGB at POST9. RYGB + ET also resulted in increased capillarization (<italic toggle="yes">P</italic> &lt; 0.01) and satellite cell content (<italic toggle="yes">P</italic> &lt; 0.01) than RYGB at POST9. Gene‐set normalized enrichment scores for the muscle transcriptome revealed that the <italic toggle="yes">ubiquitin‐mediated proteolysis</italic> pathway was suppressed in RYGB + ET at POST9 vs. PRE (NES: −1.7; <italic toggle="yes">P</italic> &lt; 0.01), but not in RYGB. <italic toggle="yes">Atrogin‐1</italic> gene expression was lower in RYGB + ET vs. RYGB at POST9 (0.18 vs. 0.71‐fold change, <italic toggle="yes">P</italic> &lt; 0.01). From both genotypic and phenotypic perspectives, the muscle of exercised patients resembled that of healthy lean individuals.</p>
                </sec>
                <sec id="jcsm12815-sec-0004">
                  <title>Conclusions</title>
                  <p>This study provides compelling evidence—from gene to function—that strongly supports the incorporation of exercise into the recovery algorithm for bariatric patients so as to counteract the post‐surgical loss of muscle mass and function.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jcsm12815-kwd-0001">Muscle atrophy</kwd>
                <kwd id="jcsm12815-kwd-0002">Obesity</kwd>
                <kwd id="jcsm12815-kwd-0003">Bariatric surgery</kwd>
                <kwd id="jcsm12815-kwd-0004">Muscle function</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>National Medical Research Council and Ministry of Health</funding-source>
                  <award-id>R913200076263</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIGMS
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000057</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P20GM103528</award-id>
                  <award-id>U54GM104940</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>Brazilian National Council for Scientific and Technological Development
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100003593</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>301571/2017‐1</award-id>
                  <award-id>400157/2016‐0</award-id>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>São Paulo Research Foundation
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100001807</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>2016/10993‐5</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="1"/>
                <page-count count="16"/>
                <word-count count="8076"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>December 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.7.0 mode:remove_FC converted:30.12.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0001"><string-name><surname>Gil</surname><given-names>S.</given-names></string-name>, <string-name><surname>Kirwan</surname><given-names>J. P.</given-names></string-name>, <string-name><surname>Murai</surname><given-names>I. H.</given-names></string-name>, <string-name><surname>Dantas</surname><given-names>W. S.</given-names></string-name>, <string-name><surname>Merege‐Filho</surname><given-names>C. A. A.</given-names></string-name>, <string-name><surname>Ghosh</surname><given-names>S.</given-names></string-name>, <string-name><surname>Shinjo</surname><given-names>S. K.</given-names></string-name>, <string-name><surname>Pereira</surname><given-names>R. M. R.</given-names></string-name>, <string-name><surname>Teodoro</surname><given-names>W. R.</given-names></string-name>, <string-name><surname>Felau</surname><given-names>S. M.</given-names></string-name>, <string-name><surname>Benatti</surname><given-names>F. B.</given-names></string-name>, <string-name><surname>de Sá‐Pinto</surname><given-names>A. L.</given-names></string-name>, <string-name><surname>Lima</surname><given-names>F.</given-names></string-name>, <string-name><surname>de Cleva</surname><given-names>R.</given-names></string-name>, <string-name><surname>Santo</surname><given-names>M. A.</given-names></string-name>, <string-name><surname>Gualano</surname><given-names>B.</given-names></string-name>, and <string-name><surname>Roschel</surname><given-names>H.</given-names></string-name> (<year>2021</year>) <article-title>A randomized clinical trial on the effects of exercise on muscle remodelling following bariatric surgery</article-title>, <source>Journal of Cachexia, Sarcopenia and Muscle</source>, <volume>12</volume>, <fpage>1440</fpage>–<lpage>1455</lpage>, <pub-id pub-id-type="doi">10.1002/jcsm.12815</pub-id>
</mixed-citation>
              </p>
            </notes>
          </front>
          <body id="jcsm12815-body-0001">
            <sec id="jcsm12815-sec-0005">
              <title>Introduction</title>
              <p>Bariatric surgery is the treatment of choice for severe obesity as it yields substantial weight loss and reversal of cardiometabolic risk factors<xref rid="jcsm12815-bib-0001" ref-type="bibr"><sup>1</sup></xref>; however, this procedure is not free of adverse outcomes. Some post‐operative patients exhibit significant loss of fat‐free mass,<xref rid="jcsm12815-bib-0002" ref-type="bibr"><sup>2</sup></xref> strength, and functionality,<xref rid="jcsm12815-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="jcsm12815-bib-0004" ref-type="bibr"><sup>4</sup></xref> which is important because these parameters are related to distinct physiological processes (e.g. immune response, regulation of glucose levels, protein synthesis, and basal metabolic rate),<xref rid="jcsm12815-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jcsm12815-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jcsm12815-bib-0007" ref-type="bibr"><sup>7</sup></xref> frailty syndrome,<xref rid="jcsm12815-bib-0008" ref-type="bibr"><sup>8</sup></xref> and most critically, mortality.<xref rid="jcsm12815-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="jcsm12815-bib-0010" ref-type="bibr"><sup>10</sup></xref>
</p>
              <p>The underlying mechanisms related to muscle atrophy following bariatric surgery remain largely underexplored. Individuals with obesity are thought to exhibit a blunted anabolic response to stimuli like exercise bouts, a condition known as anabolic resistance.<xref rid="jcsm12815-bib-0011" ref-type="bibr"><sup>11</sup></xref> This resistance has been ascribed to (i) reduced activation of proteins related to the <italic toggle="yes">mTOR</italic> pathway (a master regulator of muscle protein synthesis)<xref rid="jcsm12815-bib-0012" ref-type="bibr"><sup>12</sup></xref>; (ii) altered proteolytic activity (e.g. the ubiquitin‐proteasome system and autophagic/lysosomal system)<xref rid="jcsm12815-bib-0013" ref-type="bibr"><sup>13</sup></xref>; (iii) microvascular rarefaction<xref rid="jcsm12815-bib-0014" ref-type="bibr"><sup>14</sup></xref>; and (iv) reduced myogenic response.<xref rid="jcsm12815-bib-0015" ref-type="bibr"><sup>15</sup></xref> Whether and how these mechanisms contribute to surgery‐induced muscle atrophy remains to be determined.</p>
              <p>Exercise improves muscle mass, strength, and functionality in a wide spectrum of sub‐populations; however, whether exercise preserves muscle mass in post‐bariatric patients is controversial.<xref rid="jcsm12815-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jcsm12815-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jcsm12815-bib-0019" ref-type="bibr"><sup>19</sup></xref> Indeed, Stegen <italic toggle="yes">et al</italic>.<xref rid="jcsm12815-bib-0018" ref-type="bibr"><sup>18</sup></xref> observed higher muscle strength levels in post‐bariatric surgery patients undergoing 12 weeks of exercise training than non‐exercised patients; however, exercise did not affect fat‐free mass sparing or functionality. Conversely, Herring <italic toggle="yes">et al</italic>.<xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref> demonstrated that 12 weeks of exercise training attenuated the loss in fat‐free mass and resulted in greater strength and functionality gains in patients undergoing bariatric surgery vs. a non‐exercised group. It is noteworthy that both studies evaluated fat‐free mass using electrical bioimpedance, a method that is neither an accurate measurement of fat‐free mass in individuals with obesity<xref rid="jcsm12815-bib-0020" ref-type="bibr"><sup>20</sup></xref> nor of muscle mass. To the best of our knowledge, the only study that directly assessed muscle mass (i.e. magnetic resonance imaging) in post‐bariatric surgery patients undergoing exercise training did not detect any effect of exercise on muscle mass sparing.<xref rid="jcsm12815-bib-0019" ref-type="bibr"><sup>19</sup></xref> The dissonant findings are hard to reconcile, and in fact, literature is scarce on this subject, warranting further investigation. Moreover, the studies investigating the effects of exercise on muscle mass and function of post‐bariatric surgery patients have failed to identify mechanisms underlying exercise‐mediated muscle remodelling in this population. We<xref rid="jcsm12815-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="jcsm12815-bib-0022" ref-type="bibr"><sup>22</sup></xref> and others<xref rid="jcsm12815-bib-0023" ref-type="bibr"><sup>23</sup></xref>, <xref rid="jcsm12815-bib-0024" ref-type="bibr"><sup>24</sup></xref> have shown that exercise promotes beneficial physiological and metabolic effects that are additive to the weight loss effects of surgery, including effects on bone mass, inflammatory markers, endothelial function, and insulin sensitivity.</p>
              <p>Herein, we performed a randomized, controlled, mechanistic trial to comprehensively examine the effects of exercise training on body composition (fat‐free mass as primary outcome), muscle function and related cellular and molecular mechanisms (secondary outcomes) in women undergoing bariatric surgery. We hypothesized that exercise training following bariatric surgery would attenuate loss of fat‐free mass and conserve muscle function when compared with standard of care. We further proposed that histological and molecular analysis would generate new insights on the muscle remodelling mechanisms resulting from the surgical procedure and exercise.</p>
            </sec>
            <sec sec-type="methods" id="jcsm12815-sec-0006">
              <title>Methods</title>
              <sec id="jcsm12815-sec-0007">
                <title>Study design and human subjects</title>
                <p>This was a randomized controlled trial (registered at Clinicaltrials.gov as NCT02441361) that <italic toggle="yes">a priori</italic> aimed to investigate the effects of exercise training following bariatric surgery on multiple clinical outcomes. Specifically, this manuscript focuses on the effects of exercise training on muscle mass and function after bariatric surgery, as well as in the molecular and histological mediators of muscle remodelling. Additional reports from this trial contain data on endothelial function, bone mass, and insulin resistance were published elsewhere.<xref rid="jcsm12815-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="jcsm12815-bib-0022" ref-type="bibr"><sup>22</sup></xref>, <xref rid="jcsm12815-bib-0025" ref-type="bibr"><sup>25</sup></xref> Data were collected between March 2015 and September 2019 in São Paulo (Brazil). The study was approved by the Ethics Committee of the Clinical Hospital of the School of Medicine of the University of São Paulo, and all procedures were in accordance with the recommendations of the Helsinki Declaration. All patients provided written informed consent before being enrolled in the study. This manuscript is reported according to the guidelines of the Consolidated Standards of Reporting Trials.</p>
                <p>Patients were recruited from the Metabolic and Bariatric Surgery Unit of the Clinical Hospital of the School of Medicine of the University of São Paulo. Inclusion criteria were as follows: women who were eligible for bariatric surgery [body mass index (BMI) &gt; 40 kg/m<sup>2</sup> or ≥35 kg/m<sup>2</sup> with associated comorbidities], 18–60 years, and not engaged in an exercise training programme for at least 1 year prior to the study. Exclusion criteria involved cancer in the past 5 years, and any cardiovascular diseases, neurological disorders, or skeletal muscle impairment that would contraindicate exercise practice. None of the patients were receiving hormone replacement therapy.</p>
                <p>Before surgery, patients were randomly assigned (1:1) into either a Roux‐en‐Y gastric bypass (RYGB) or Roux‐en‐Y gastric bypass plus exercise training group (RYGB + ET), using a computer‐generated randomization code. Clinical and laboratory parameters were assessed at baseline (PRE), and 3 (POST3) and 9 (POST9) months after the surgery. The 6 month exercise intervention (for the exercise group) started at POST3 upon post‐surgery medical clearance for high‐intensity exercise participation. A healthy control group comprising lean, age‐matched women was also recruited and assessed to provide reference values for selected variables.</p>
              </sec>
              <sec id="jcsm12815-sec-0008">
                <title>Exercise intervention</title>
                <p>The RYGB + ET group participated in a 6 month, three‐times‐a‐week, supervised exercise training programme at the hospital, whereas the RYGB group received standard post‐surgery care during follow‐up. Training sessions included a 5 min light warm‐up followed by strengthening exercises for the major muscle groups (leg‐press 45°, leg extension, half‐squat, bench press, lat pulldown, seated row, and calf raise) and aerobic exercise on a treadmill. The resistance exercise protocol was comprised of three sets of 8–12 repetition maximum with a 60 s rest interval between sets and exercises. Load progression (5%) was employed as soon as patients were able to perform two or more repetitions than previously determined. Aerobic training consisted of 30–60 min (10 min progression every 4 weeks) of treadmill walking at an intensity corresponding to 50% of the delta difference between the ventilatory anaerobic threshold and respiratory compensation point. Heart rate was monitored throughout every session to ensure proper exercise intensity (Polar®). Any adverse events or signs and symptoms were documented including feelings of general fatigue, soft tissue soreness, and injury or illness; and a record of attendance was kept ensuring adherence to the protocol.</p>
              </sec>
              <sec id="jcsm12815-sec-0009">
                <title>Body weight and composition</title>
                <p>Body weight was assessed on a calibrated digital scale and height was evaluated with the aid of a stadiometer, from which BMI was calculated. All patients underwent a whole‐body dual‐energy x‐ray absorptiometry scan (GE Healthcare®) to quantify fat mass and lean mass using CoreScan™ software. All dual‐energy x‐ray absorptiometry measurements were carried out by the same trained technician.</p>
              </sec>
              <sec id="jcsm12815-sec-0010">
                <title>Muscular strength rest (1‐RM) and functionality</title>
                <p>Before testing, all patients performed two familiarization sessions separated by at least 72 h. Lower‐ and upper‐limb maximal dynamic strength was assessed in the leg‐press (45°) and bench‐press, respectively (Nakagym, São Paulo, Brazil). Coefficient of variation for 1RM in the leg‐press and bench‐press were 2.8% and 1.1%, respectively.</p>
                <p>Functionality was measured by the timed‐stands test and the timed‐up‐and‐go test. The timed‐stands test evaluates the maximum number of stands that an individual can perform from a standard‐height armless‐chair (i.e. 45 cm), whereas the timed‐up‐and‐go test registers the minimal time (in seconds) that each individual requires to rise from a standard chair, walk to a line on the floor 3 m away, turn around, and sit down again. Two attempts were allowed for each test. All tests were conducted by the same investigator to avoid bias. Coefficient of variation for timed‐stands test and timed‐up‐and‐go test were 2.1% and 3.5%, respectively.</p>
              </sec>
              <sec id="jcsm12815-sec-0011">
                <title>Physical activity monitoring</title>
                <p>Physical activity levels and sedentary behaviour were objectively measured using ActiGraph GT3X® accelerometers (ActiGraph, Pensacola, Florida). Patients were instructed to wear the accelerometer for seven consecutive days during waking hours, except when bathing. Physical activity was assessed during non‐training periods [i.e. at PRE, before the commencement of exercise intervention (POST3), and after the completion of the exercise intervention (POST9)]. All patients were required to accumulate at least 10 h of valid activity recordings per day for at least five days. The accelerometer was worn on an elastic belt at the waistline on the right side of the hip. To accurately register when the device was worn and removed, patients kept a daily log. Data were exported from the device in 60 s epochs, using ActiLife 6 software (ActiGraph, Pensacola, Florida). Non‐wear periods were defined as intervals of at least 60 min of zero activity counts, assuming a tolerance of no more than 2 min of counts between 0 and 100. Freedson <italic toggle="yes">et al</italic>.<xref rid="jcsm12815-bib-0026" ref-type="bibr"><sup>26</sup></xref> cut‐points were used to define epochs as follows: sedentary time (&lt;100 counts per minute), light‐intensity physical activity (≥100 to &lt;1952 counts per minute), and moderate‐to‐vigorous physical activity (≥1952 counts per minute). Sedentary behaviour and moderate‐to‐vigorous physical activity data are presented as minute per day.</p>
              </sec>
              <sec id="jcsm12815-sec-0012">
                <title>Muscle biopsies</title>
                <p>All percutaneous muscle biopsy procedures were performed by a trained physician. The patients assumed a comfortable reclining position with both legs outstretched. The <italic toggle="yes">vastus lateralis</italic> biopsy site, (at a point 10–15 cm proximal from the tibial tuberosity and 5 cm lateral from the midline of the femoral course), was prepared with chlorhexidine gluconate solution. Skin and subcutaneous tissue were infiltrated with a 3 mL lidocaine hydrochloride 2% <italic toggle="yes">w</italic>/<italic toggle="yes">v</italic> solution, ensuring that the <italic toggle="yes">fascia lata</italic> was well infiltrated. After ensuring adequate local anaesthesia, an incision was made in the lateral thigh at the biopsy site directly through the overlying skin, subcutaneous fat, and <italic toggle="yes">fascia lata</italic>. A 5 mm modified Bergström needle was then inserted through the fascia, and an assistant immediately applied suction using a 60 mL syringe connected to a canister and attached to the top of the needle. A muscle sample was removed, and the skin was closed with skin closure tape. To minimize risk of infection and bruising, a pressure dressing was immediately applied and maintained for 72 h. All post‐intervention biopsies were performed 72 h following the last exercise session at an adjacent distal incision to the baseline site, approximately 0.5 cm apart. There were no adverse events related to the procedure.</p>
              </sec>
              <sec id="jcsm12815-sec-0013">
                <title>Immunohistochemistry</title>
                <p>Frozen muscles were embedded in optimal cutting temperature compound and were sectioned (7 μm thick) on a cryostat. For fibre immunostaining assay, muscle samples were brought to room temperature and fixed in methanol for 10 min, washed [three 10 min washes with phosphate‐buffered saline (PBS)], then blocked for 60 min in a blocking buffer solution (containing 1% PBS, 5% bovine serum albumin, and 0.3% Triton X‐100). The slides were then incubated with primary antibody overnight at 4°C. The next day, slides were again washed (three 10 min washes with PBS) and incubated in appropriate secondary antibody in the dark for 1 h at room temperature. Nuclei were labelled using fluoroshield mounting medium with DAPI (Ab104139, Abcam), prior to cover slipping slides. Images were captured with an Olympus BX51 Fluorescence microscope with a magnification of ×20. For Type I and Type II fibre cross‐sectional area (fCSA), myonuclei and satellite cell content (SC), a minimum of 120 fibres per subject at each time point was analysed.<xref rid="jcsm12815-bib-0027" ref-type="bibr"><sup>27</sup></xref> The quantification of muscle fibre capillaries [capillary contacts (CC, the number of capillaries around a fibre), capillary‐to‐fibre ratio on an individual fibre basis (C/Fi), and capillary‐to‐fibre perimeter exchange index (CFPE, an estimate of the capillary‐to‐fibre surface area)] were performed on 50 muscle fibres/subject/time point, as previously described.<xref rid="jcsm12815-bib-0028" ref-type="bibr"><sup>28</sup></xref> All immunohistochemical images were analysed by a single researcher in a blinded manner. Coefficient of variation between two blinded measurements were 3.7%, 3.5%, 3.7%, 3.3%, 3.3%, 4.4%, 2.6%, and 3.4% for Types I and II muscle fCSA, Types I and II muscle fibre myonuclei content, Types I and II muscle fibre myonuclear domain, CC, C/Fi, CFPE, and SC, respectively.</p>
              </sec>
              <sec id="jcsm12815-sec-0014">
                <title>RNA‐sequencing and bioinformatics analysis</title>
                <p>For RNA sequencing (RNA‐seq), muscle RNA was isolated (six patients per group) using the RNeasy Fibrous Tissue Mini Kit (Qiagen®). Total RNA concentration was assessed spectrophotometrically at 260 nm (GE Healthcare®) and RNA integrity number (RIN ≥ 7) was checked using a Bioanalyzer 2100 (Agilent®). RNA library construction and sequencing were performed in the Genomics Core at Pennington Biomedical Research Center. Sample concentration was normalized and cDNA pools were created for each sample, and subsequently tagged with a barcoded oligo adapter to allow for sample specific resolution using the Quant‐seq® 3′ mRNA‐Seq Library Prep Kit (Lexogen®). Sequencing was carried out using an Illumina Seq 2500 platform (Illumina®) with 75 <sc>bp</sc> single end reads. Reads were aligned to the human‐reference genome (GRCh38.77). Annotation and preparation of the sequencing data for downstream analysis was performed by custom <italic toggle="yes">R</italic> scripts<xref rid="jcsm12815-bib-0029" ref-type="bibr"><sup>29</sup></xref> with annotations downloaded from BioMart (R.V3.4.3, Rstudio V1.1.423 and biomaRt V2.24.1). Quant‐Seq raw data are available in the NCBI GEO database (accession GSE 137631).</p>
                <p>Raw count data were normalized via TMM normalization in edgeR<xref rid="jcsm12815-bib-0030" ref-type="bibr"><sup>30</sup></xref> and adjusted for mean–variance effects via the voom function in limma.<xref rid="jcsm12815-bib-0031" ref-type="bibr"><sup>31</sup></xref> Differential gene expression analysis was performed via the limma empirical Bayes analysis pipeline by adjusting the model design matrix using paired or unpaired analysis, depending upon the specific contrasts. Genes with a false discovery rate (FDR) ≤ 0.05 were considered as differentially expressed. Pathway enrichment analysis was carried out via the gene set enrichment analysis (GSEA) pre‐ranked method by querying a ‘custom’ database consisting of gene‐sets from Wikipathways (<ext-link xlink:href="http://www.wikipathways.org" ext-link-type="uri">www.wikipathways.org</ext-link>) plus user‐defined gene sets corresponding to specific biological functions. Pathway enrichments with an FDR ≤ 10% and the absolute normalized enrichment score (NES) ≥ 1.5 were considered significant.</p>
              </sec>
              <sec id="jcsm12815-sec-0015">
                <title>Quantitative real‐time PCR</title>
                <p>Total muscle RNA was lysed in 1 mL of TRIzol reagent (Invitrogen®) and RNA was isolated using standard techniques. The Superscript Platinum One‐Step kit (Invitrogen®), with incorporated Maxima SYBR Green/ROX qPCR Master Mix (Thermo Fisher Scientific®) on a Step One™ Real‐Time PCR System (Applied Biosystems®) was used to perform the qRT‐PCR experiments. All primers were purchased from Invitrogen®. The fold changes from PRE were calculated using the 2<sup><italic toggle="yes">−ΔΔCt</italic></sup> method,<xref rid="jcsm12815-bib-0032" ref-type="bibr"><sup>32</sup></xref> and all mRNA levels were normalized to beta‐2‐microglobulin (<italic toggle="yes">β2M</italic>).</p>
              </sec>
              <sec id="jcsm12815-sec-0016">
                <title>Western blotting</title>
                <p>Protein extraction followed by quantification was performed via Western blotting as described previously.<xref rid="jcsm12815-bib-0033" ref-type="bibr"><sup>33</sup></xref> In brief, cell lysates (30–40 μg) were resolved by sodium dodecyl polyacrylamide gel electrophoresis, electrophoresis to PVDF membrane, and incubated overnight with appropriate primary antibodies followed by incubation in appropriate HRP tagged secondary antibody. Signals were revealed by enhanced chemiluminescence ECL reagent (SuperSignal™ West Femto Substrate, Thermo Fisher Scientific). Gel‐to‐gel variation and equal protein loading were controlled using a standardized sample on each gel. Results were corrected to Ponceau red staining (0.5%, w:v) of the membrane for all immunoblot assays.<xref rid="jcsm12815-bib-0034" ref-type="bibr"><sup>34</sup></xref> Blots were quantified using the Image‐J software®. Details of all reagents and resources are provided in supporting information, <italic toggle="yes">Table</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S1</xref>.</p>
              </sec>
              <sec id="jcsm12815-sec-0017">
                <title>Sample size calculation and statistical analysis</title>
                <p>Sample size was determined with the aid of a G‐Power software (version 3.1.2—<italic toggle="yes">Universitat Kiel</italic>, Germany) package. The analysis was conducted by inputting α error (0.05), power (1 − β error = 0.90), and effect size (Hedges' g = 0.20), considering previous data indicating moderate between‐group effect size (RYGB vs. RYGB + ET) for fat‐free mass in individuals undergoing bariatric surgery.<xref rid="jcsm12815-bib-0018" ref-type="bibr"><sup>18</sup></xref> Calculations were based on an ANOVA with repeated measures (within‐between interactions) and the total sample size was determined to be 56 patients. To account for midtrial withdrawals, the sample was increased by ~40% (i.e. 80 patients).</p>
                <p>Data are presented as mean ± standard deviation (SD), estimated mean difference between groups (EMD) at POST9 (only in the presence of group x time interaction), 95% confidence interval (95%CI), unless otherwise indicated. Baseline characteristics were compared between the two groups using either Student's <italic toggle="yes">t</italic> test or Fisher exact test. The data were analysed using an intention‐to‐treat (ITT) approach to preserve the integrity of randomization. Dependent variables were analysed by a mixed model analysis for repeated measures, using group (RYGB and RYGB + ET group) and time (PRE, POST3, and POST9) as fixed factors, and subjects as a random factor using SAS software version 9.1. <italic toggle="yes">Post‐hoc</italic> tests with Tukey's adjustment were performed for multiple comparisons. Additionally, in order to verify efficacy of the exercise training in body composition parameters, <italic toggle="yes">independent t tests</italic> were performed to test possible between‐group differences in absolute changes (∆) between POST9 to PRE. To compare experimental groups (RYGB vs. RYGB + ET) at POST9 with reference values from healthy women lean control group, values of muscle strength, functionality, capillarization, and SC content were transformed into standardized scores (i.e. <italic toggle="yes">Z</italic>‐score) having mean ± SD values of the CTRL as reference for each assessment. In this analysis it is assumed that the closer the <italic toggle="yes">Z</italic>‐scores are to zero the more comparable they are to the healthy women in the lean control group. In addition, in order to statistically compare the <italic toggle="yes">Z</italic>‐score of each dependent variable of the non‐exercise and exercise group with women in the healthy lean control group, a one‐way ANOVA was performed, and in case of <italic toggle="yes">F</italic>‐value significant, <italic toggle="yes">post‐hoc</italic> tests with <italic toggle="yes">Dunnett</italic>'s adjustment were performed for multiple comparisons. Significance level was set at <italic toggle="yes">P ≤</italic> 0.05. To facilitate the reader, main effects of time are described as effects of surgery (POST3‐PRE), whereas group × time interactions at POST9 are described as effects of exercise, unless otherwise stated.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jcsm12815-sec-0018">
              <title>Results</title>
              <sec id="jcsm12815-sec-0019">
                <title>Flow of participants</title>
                <p>The flow of participants through the study is depicted in <italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S1</xref>. Three‐hundred and thirty‐eight patients were screened for participation. Eighty patients met inclusion criteria and were randomly (computer‐generated randomization code) assigned (1:1) to either RYGB (<italic toggle="yes">n</italic> = 40) or RYGB + ET (<italic toggle="yes">n</italic> = 40). Thirteen patients dropped out of the RYGB group (did not perform surgery: <italic toggle="yes">n</italic> = 9; personal reasons: <italic toggle="yes">n</italic> = 4) and 12 dropped out from the RYGB + ET group before the intervention (did not perform surgery: <italic toggle="yes">n</italic> = 7; personal reasons: <italic toggle="yes">n</italic> = 5). Patients from the RYGB + ET group attended 83 ± 11% of the exercise training sessions. Both groups were comparable regarding baseline characteristics (<italic toggle="yes">Table</italic>
<xref rid="jcsm12815-tbl-0001" ref-type="table">1</xref>).</p>
                <table-wrap position="float" id="jcsm12815-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline characteristics of the participants</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="±" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="±" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Outcomes</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">RYGB (<italic toggle="no">n</italic> = 40)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">RYGB+ET (<italic toggle="yes">n</italic> = 40)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1"><italic toggle="no">P</italic> value</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Healthy lean control group (<italic toggle="no">n</italic> = 20)</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Age, years</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">42 ± 8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">38 ± 7</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.0719</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">38 ± 6</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Body composition</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Body mass, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">124.6 ± 21.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">127.0 ± 22.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.6159</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">63.1 ± 5.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">47.4 ± 7.6</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">48.9 ± 6.5</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.3533</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">21.8 ± 1.4</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fat mass, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">62.9 ± 14.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">65.5 ± 14.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.4314</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">15.6 ± 3.0</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Fat‐free mass, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">56.6 ± 6.9</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">56.2 ± 7.2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.8504</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">41.4 ± 6.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Lower‐limb fat‐free mass, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">20.9 ± 3.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">21.5 ± 3.5</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.5237</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">14.0 ± 1.6</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Upper‐limb fat‐free mass, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6.4 ± 0.8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6.1 ± 1.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.2396</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.3 ± 0.9</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Medication</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">β‐blockers, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5 (12.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">4 (10.0)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">&gt;0.9999</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Metformin, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5 (12.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">6 (15.0)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">&gt;0.9999</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Insulin, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5 (12.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2 (5.0)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.4315</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">ACE inibitor, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5 (12.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">7 (17.5)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.7555</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Calcium channel blocker, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1 (2.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2 (5.0)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">&gt;0.9999</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Angiotensin II receptor antagonism, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">9 (22.5)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">8 (20.0)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">&gt;0.9999</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Diuretics, <italic toggle="yes">n</italic> (%)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">10 (25.0)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">11 (27.5)</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">&gt;0.9999</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">‐</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Muscle function</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1‐RM leg‐press, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">190 ± 60</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">201 ± 56</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.4337</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">177 ± 37</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1‐RM leg‐press, kg/body mass</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.5 ± 0.49</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">1.6 ± 0.5</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.6283</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">2.9 ± 0.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1‐RM bench‐press, kg</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">36 ± 8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">38 ± 8</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.4198</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">33 ± 12</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">1‐RM bench‐press, kg/body mass</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.3 ± 0.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.3 ± 0.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.7625</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.5 ± 0.2</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Timed‐up‐and‐go, s</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">7.6 ± 1.1</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">7.4 ± 1.0</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.6339</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4.7 ± 0.4</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Timed‐stands, reps</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">13 ± 2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">14 ± 2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.0820</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">22 ± 2</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Physical activity level</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sedentary behaviour, min/day</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">538 ± 110</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">588 ± 162</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.3006</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">587 ± 82</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Sedentary behaviour, %/day</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">65 ± 10</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">67 ± 10</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.5560</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">67 ± 5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MVPA, min/day</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">26 ± 13</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">37 ± 28</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.1745</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">57 ± 22</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MVPA, %/day</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">3 ± 2</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">4 ± 3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.2170</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">6 ± 2</td>
                      </tr>
                      <tr>
                        <td colspan="5" align="left" valign="top" rowspan="1">Cardiorespiratory fitness</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">VAT, mL/kg/min</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">8.6 ± 1.72</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">9.6 ± 2.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.2020</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">16.5 ± 5.2</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">RCP, mL/kg/min</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">13.8 ± 2.21</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">14.0 ± 2.4</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.6839</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">27.5 ± 6.6</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">VO<sub>2 peak</sub>, mL/kg/min</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">15.5 ± 2.7</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">15.8 ± 2.3</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">0.5453</td>
                        <td align="char" valign="top" rowspan="1" colspan="1">33.2 ± 6.8</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jcsm12815-ntgp-0001">
                    <fn id="jcsm12815-note-0001">
                      <p>Data are expressed as mean ± SD or number of patients (%). 1‐RM: maximal dynamic strength; ACE, angiotensin‐converting enzyme; MVPA, moderate‐to‐vigorous physical activity; RCP, respiratory compensation point; RYGB + ET: Roux‐en‐Y gastric bypass plus exercise training group; RYGB: Roux‐en‐Y gastric bypass plus non‐exercise group; VAT, ventilatory anaerobic threshold; VO<sub>2 peak</sub>, peak oxygen uptake.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jcsm12815-sec-0020">
                <title>Changes in body composition</title>
                <p>The BMI, fat mass, total fat‐free mass, and lower‐limb and upper‐limb fat‐free mass were reduced at 3 and 9 months after surgery (main effect of time: all <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0001" ref-type="fig">1</xref>, Panels A, C, E, and G). Additionally, delta analysis (POST9‐PRE) revealed that reductions in total (RYGB: ∆: −7.9 kg; RYGB + ET: ∆: −4.9 kg; between group comparison: ∆: −3.0 kg; 95% CI: −4.54 to −1.60; <italic toggle="yes">P</italic> = 0.0042) and lower‐limb fat‐free mass (RYGB: ∆: −3.8 kg; RYGB + ET: ∆: 2.7 kg; between group comparison: ∆: −1.1 kg; 95%CI: −0.47 to −1.77; <italic toggle="yes">P</italic> = 0.0268) were greater in RYGB in comparison to RYGB + ET (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0001" ref-type="fig">1</xref>, Panels B, D, F, and H, respectively), indicating that exercise training preserved total and lower‐limb fat‐free mass in the exercised group. In contrast, delta analysis (POST9‐PRE) did not detect between‐group difference for upper‐limb fat‐free mass (RYGB: ∆: −1.7 kg; RYGB + ET: ∆: −1.7 kg; between group comparison: ∆: 0.0 kg; 95% CI: −0.54 to 0.54; <italic toggle="yes">P</italic> = 0.9556).</p>
                <fig position="float" fig-type="Figure" id="jcsm12815-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <p>Changes in body composition. RYGB + ET (<italic toggle="no">n</italic> = 28): Roux‐en‐Y gastric bypass plus exercise training group; RYGB (<italic toggle="no">n</italic> = 27): Roux‐en‐Y gastric bypass plus non‐exercise. Body mass index (BMI), fat mass, fat‐free mass, and lower‐ and upper‐limb fat‐free mass in the experimental groups (Panels <italic toggle="no">A, C, E, G</italic>, and <italic toggle="yes">I</italic>, respectively). Absolute changes (∆) from POST9 to PRE for BMI, fat mass, fat‐free mass, lower‐limb fat‐free mass (Panels <italic toggle="no">B, D, F, H</italic>, and <italic toggle="yes">J</italic>, respectively). Data are expressed as mean ± SD. PRE, before surgery (baseline); POST3, 3 months following surgery; POST9, 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time.</p>
                  </caption>
                  <graphic xlink:href="JCSM-12-1440-g005" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="jcsm12815-sec-0021">
                <title>Muscular strength, functionality, and physical activity level</title>
                <p>There were significant decreases in absolute and relative lower‐ and upper‐limb muscle strength following surgery (main effect of time: both <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0002" ref-type="fig">2</xref>, Panels A–D). Importantly, the RYGB+ET group showed absolute and relative lower‐limb muscle strength (EMD: 83.2 kg; 95% CI: 43.2 to 122.8; <italic toggle="yes">P</italic> &lt; 0.0001; EMD: 0.9 kg/body mass, 95% CI: 0.4 to 1.3; <italic toggle="yes">P</italic> &lt; 0.0001, respectively) and absolute upper‐limb muscle strength (EMD: 5.4 kg; 95% CI: 0.03 to 10.9, <italic toggle="yes">P</italic> = 0.0529) than the RYGB group at POST9 (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0002" ref-type="fig">2</xref>, Panels A–D). Functional tests, including the timed‐up‐and‐go and timed‐stands scores improved 9 months following surgery in both groups (RYGB + ET: both <italic toggle="yes">P</italic> &lt; 0.0001; RYGB: <italic toggle="yes">P</italic> = 0.0008 and <italic toggle="yes">P</italic> = 0.012, respectively); however, the RYGB + ET group performed better than the RYGB group in timed‐up‐and‐go (EMD: 0.2 s, 95% CI: −0.1 to 1.4, <italic toggle="yes">P</italic> = 0.0566) and timed‐stands tests (EMD: 3.5 repetitions, 95% CI: 1.7 to 5.3, <italic toggle="yes">P</italic> &lt; 0.0001, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0002" ref-type="fig">2</xref>, Panels E and F). Physical activity levels were unchanged in both groups (all <italic toggle="yes">P</italic> &gt; 0.05) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0002" ref-type="fig">2</xref>, Panels G and H).</p>
                <fig position="float" fig-type="Figure" id="jcsm12815-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <p>Muscular strength, functionality, and physical activity level. RYGB + ET (<italic toggle="no">n</italic> = 28): Roux‐en‐Y gastric bypass plus exercise training group; RYGB (<italic toggle="no">n</italic> = 27): Roux‐en‐Y gastric bypass plus non‐exercise. Absolute and relative lower‐limb (Panels <italic toggle="no">A</italic> and <italic toggle="no">B</italic>, respectively) and upper‐limb (Panels <italic toggle="no">C</italic> and <italic toggle="no">D</italic>, respectively) strength performance in the 1‐RM test. Functionality in the timed‐up‐and‐go test and timed‐stand test (Panels <italic toggle="yes">E</italic> and <italic toggle="yes">F</italic>, respectively). Time spent in sedentary behaviour and moderate‐to‐vigorous physical activity level (Panels <italic toggle="no">G</italic> and <italic toggle="no">H</italic>, respectively). Data are expressed as mean ± SD. PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery; ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time. * indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison with PRE; <sup>#</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison with POST3; <sup>$</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 for between‐group comparison with POST9.</p>
                  </caption>
                  <graphic xlink:href="JCSM-12-1440-g004" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
              <sec id="jcsm12815-sec-0022">
                <title>Muscle fibre cross‐sectional area, myonuclei content, myonuclear domain, muscle fibre capillarization, and satellite cell content</title>
                <p>To further examine the effect of exercise on muscle remodelling, we performed immunostaining assays from <italic toggle="yes">vastus lateralis</italic> samples to assess adaptations at the muscle fibre level, specifically Type I and Type II muscle fCSA, satellite cell content, and capillarization (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0003" ref-type="fig">3</xref>, Panels A, H, and L, respectively). Type I and Type II fCSA decreased 3 months following surgery in both groups (main effect of time: both <italic toggle="yes">P</italic> &lt; 0.0001). The RYGB + ET group showed greater Type I fCSA (EMD: 1289.2 μm<sup>2</sup>, 95% CI: 355.7 to 2222.6, <italic toggle="yes">P</italic> = 0.0025) and Type II fCSA (EMD: 1600.1 μm<sup>2</sup>, 95% CI: 468.4 to 2731.8, <italic toggle="yes">P</italic> = 0.0019) than the RYGB group (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0003" ref-type="fig">3</xref>, Panels B and C) at POST9. Of relevance, Types I and II fCSA in the RYGB + ET reached pre‐surgery levels (<italic toggle="yes">P</italic> &gt; 0.05).</p>
                <fig position="float" fig-type="Figure" id="jcsm12815-fig-0003">
                  <label>Figure 3</label>
                  <caption>
                    <p>Muscle fibre cross‐sectional area, myonuclei content, myonuclear domain, muscle fibre capillarization, and satellite cell content. RYGB + ET (<italic toggle="no">n</italic> = 11): Roux‐en‐Y gastric bypass plus exercise training group; RYGB (<italic toggle="no">n</italic> = 11): Roux‐en‐Y gastric bypass plus non‐exercise. A representative image of the immunofluorescence staining for analysis of Types I and II muscle fibre cross‐sectional area (fCSA), myonuclei content, myonuclear domain (Panel <italic toggle="no">A</italic>), satellite cells content (Panel <italic toggle="no">H</italic>), and capillarization (Panel <italic toggle="no">J</italic>). Types I and II muscle fibre cross‐sectional area (fCSA) (Panels <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>, respectively), myonuclei content (Panels <italic toggle="no">D</italic> and <italic toggle="no">E</italic>, respectively), myonuclear domain (Panels <italic toggle="no">F</italic> and <italic toggle="no">G</italic>, respectively), satellite cells content (Panel <italic toggle="no">I</italic>), capillary contacts (CC) (Panel <italic toggle="no">K</italic>), capillary‐to‐fibre ratio on an individual fibre basis (C/Fi) (Panel <italic toggle="no">L</italic>), and capillary‐to‐fibre perimeter exchange index (CFPE) (Panel <italic toggle="no">M</italic>). Data are expressed as mean ± SD. PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time; * indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison with PRE; <sup>#</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison with POST3; <sup>$</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 for between‐group comparison with POST9.</p>
                  </caption>
                  <graphic xlink:href="JCSM-12-1440-g001" position="anchor" id="jats-graphic-5"/>
                </fig>
                <p>The satellite cell pool was increased after the intervention in the RYGB + ET group, whereas no changes were noted in the RYGB group across time (both <italic toggle="yes">P</italic> &gt; 0.05). Of relevance, the RYGB + ET group had a larger satellite cell pool than the RYGB group after the intervention (EMD: 0.04 satellite cell/fibre; 95% CI: 0.01 to 0.06; <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0003" ref-type="fig">3</xref>, Panel I). Both groups demonstrated reduced Type I muscle fibre myonuclei content at POST3 and POST9 vs. PRE (<italic toggle="yes">P</italic> &lt; 0.0001 and <italic toggle="yes">P</italic> = 0.0308, respectively).</p>
                <p>The RYGB + ET group increased the expression of the angiogenesis markers <italic toggle="yes">ANGP1</italic>, <italic toggle="yes">ANGP2</italic>, <italic toggle="yes">TEK</italic>, and <italic toggle="yes">VEGF</italic> (EMD: 2.2 fold change; 95% CI: 0.4 to 4.1; <italic toggle="yes">P</italic> &lt; 0.0071; EMD: 4.0 fold change; 95% CI: 2.8 to 5.3; <italic toggle="yes">P</italic> &lt; 0.0001; EMD: 1.6 fold change; 95% CI: 0.7 to 2.6; <italic toggle="yes">P</italic> &lt; 0.0001; EMD: −241.5 fold change; 95% CI: −438.9 to −44.2; <italic toggle="yes">P</italic> &lt; 0.0083, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S2</xref>, Panels B, C, E, and G, respectively). Accordingly, the RYGB + ET group showed greater muscle fibre capillarization (assessed by CC, C/Fi, and CFPE) than the RYGB group at POST9 (EMD: 1.5 capillary contacts; 95% CI: 1.0 to 2.0; <italic toggle="yes">P</italic> &lt; 0.0001; EMD: 0.5 C/Fi; 95% CI: 0.3 to 0.7; <italic toggle="yes">P</italic> &lt; 0.0001; EMD: 1.4 CFPE; 95% CI: 0.6 to 2.2; <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0003" ref-type="fig">3</xref>, Panels K, L, and M, respectively).</p>
              </sec>
              <sec id="jcsm12815-sec-0023">
                <title>Pathway enrichment analysis related to muscle plasticity, gene, and protein expression of muscle remodelling pathways</title>
                <p>Gene set enrichment analysis revealed that the <italic toggle="yes">ubiquitin‐mediated proteolysis</italic> pathway was significantly suppressed in the RYGB + ET group at POST9 vs. PRE (NES: −1.7; <italic toggle="yes">P</italic> &lt; 0.01; FDR: 0.09), whereas no changes were observed in the RYGB group (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0004" ref-type="fig">4</xref>, Panels A and B, respectively). Supporting the RNA‐seq data, <italic toggle="yes">Atrogin‐1</italic> gene expression was lower in the RYGB + ET vs. RYGB group (EMD: −1.9‐fold change; 95% CI: −3.0 to −0.8; <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0004" ref-type="fig">4</xref>, Panel C).</p>
                <fig position="float" fig-type="Figure" id="jcsm12815-fig-0004">
                  <label>Figure 4</label>
                  <caption>
                    <p>Pathway enrichment analysis related to muscle plasticity, gene and protein expression of atrogin‐1 and MuRF‐1. RYGB+ET [<italic toggle="no">n</italic> = 14(8 for western blot)]: Roux‐en‐Y gastric bypass plus exercise training group; RYGB [<italic toggle="no">n</italic> = 14 (8 for western blot)]: Roux‐en‐Y gastric bypass plus non‐exercise. Gene set enrichment analysis (GSEA) related to muscle protein synthesis and breakdown (Panel <italic toggle="no">A</italic>) and the GSEA‐plot of the ubiquitin mediated proteolysis pathway (Panel <italic toggle="no">B</italic>). Gene and protein expression for <italic toggle="no">Atrogin‐1</italic> (Panels <italic toggle="no">C</italic> and <italic toggle="no">E</italic>, respectively) and <italic toggle="no">MuRF‐1</italic> (Panels <italic toggle="no">D</italic> and <italic toggle="no">F</italic>, respectively). Representative image of the Western blot bands for <italic toggle="no">Atrogin‐1</italic> and <italic toggle="no">MuRF‐1</italic> (Panel <italic toggle="no">H</italic>). Data are expressed as mean ± SD. Red arrow indicates an enrichment with a false discovery rate (FDR) ≤ 10% and the absolute log2 fold‐change &gt;1.5; PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time; * indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison to PRE; <sup>#</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison to POST3; <sup>$</sup> indicates <italic toggle="no">P</italic> &lt; 0.05 for between‐group comparison at POST9.</p>
                  </caption>
                  <graphic xlink:href="JCSM-12-1440-g002" position="anchor" id="jats-graphic-7"/>
                </fig>
                <p>Our data indicated a decreased expression of the autophagy system‐related genes <italic toggle="yes">BNIP3</italic> and <italic toggle="yes">CTSL1</italic> at 3 and 9 months after the surgery, independent of exercise (both <italic toggle="yes">P</italic> &lt; 0.0001) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S3</xref>, Panels A and C, respectively).</p>
                <p><italic toggle="yes">mTOR</italic> pathway‐related proteins, <italic toggle="yes">p‐4E‐BP1/4E‐BP1</italic> was reduced at POST9 and POST3 vs. PRE, independent of exercise (main effect of time: <italic toggle="yes">P</italic> = 0.0125 and <italic toggle="yes">P</italic> = 0.0412, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S4</xref>, Panel I). However, no significant changes were observed in <italic toggle="yes">mTOR</italic> and <italic toggle="yes">P70S6K</italic> because of surgery and exercise (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S4</xref>, Panels A–H).</p>
              </sec>
              <sec id="jcsm12815-sec-0024">
                <title>Muscle genotype and phenotype of post‐bariatric patients in comparison with healthy lean controls</title>
                <p>To investigate the extent to which exercise may rescue muscle genotype and phenotype in patients who underwent bariatric surgery, we compared the RNA‐seq data from RYGB + ET and RYGB groups (at POST9) vs. healthy lean control group. In comparison with controls, the RYGB + ET group showed a much lower number of differentially expressed genes (276 genes) than the RYGB group (544 genes), with genes at FDR ≤ 0.05 being defined as differentially expressed. (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panel A). Interestingly, GSEA did not show any significant difference between the RYGB + ET group and controls (all <italic toggle="yes">P</italic> &gt; 0.05), whereas pathways related to the ubiquitin‐proteasome system (i.e. <italic toggle="yes">FOXO signalling pathway and ubiquitin‐mediated proteolysis</italic>) were up‐regulated in the RYGB group vs. controls (<italic toggle="yes">FOXO signalling pathway</italic>: NES: 1.68, FDR: 0.2117, <italic toggle="yes">P</italic> = 0.0316; <italic toggle="yes">ubiquitin proteolysis pathway</italic>: NES: 2.34, FDR: 0.0545, <italic toggle="yes">P</italic> = 0.0020) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panel B).</p>
                <fig position="float" fig-type="Figure" id="jcsm12815-fig-0005">
                  <label>Figure 5</label>
                  <caption>
                    <p>Normalized skeletal muscle cell signalling pathways and physiological outcomes. RYGB + ET: Roux‐en‐Y gastric bypass plus exercise training group; RYGB: Roux‐en‐Y gastric bypass plus non‐exercise. Venn diagram of the total number of differentially expressed genes (FDR ≤ 0.05), and gene set enrichment analysis (GSEA) related to muscle protein synthesis and breakdown in the RYGB + ET and RYGB groups at POST9 in comparison with healthy lean control group (Panels <italic toggle="no">A</italic> and <italic toggle="no">B</italic>, respectively). Comparison of the RYGB + ET and RYGB groups at POST9 with reference values from healthy lean control group: <italic toggle="no">Z</italic>‐score for absolute and relative lower‐limb (Panels <italic toggle="no">C</italic> and <italic toggle="no">D</italic>, respectively) and upper‐limb (Panels <italic toggle="no">E</italic> and <italic toggle="no">F</italic>, respectively) strength performance in the 1‐RM test, functionality in the timed‐up‐and‐go test and timed‐stand test (Panels <italic toggle="no">G</italic> and <italic toggle="no">H</italic>, respectively), Types I and II muscle fibre cross‐sectional area (CSA) (Panels <italic toggle="no">I</italic> and <italic toggle="no">J</italic>, respectively), muscle fibre capillarization parameters (Panels <italic toggle="no">K</italic>, <italic toggle="no">L</italic>, and <italic toggle="no">M</italic>, respectively) and satellite cell content (Panel <italic toggle="no">N</italic>). Data are expressed as mean ± SD. Red arrow indicates an enrichment with a false discovery rate (FDR) ≤ 10% and the absolute log2 fold‐change &gt;1.5; PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. * indicates <italic toggle="no">P</italic> &lt; 0.05 in comparison with healthy lean control group.</p>
                  </caption>
                  <graphic xlink:href="JCSM-12-1440-g003" position="anchor" id="jats-graphic-9"/>
                </fig>
                <p>To further examine whether skeletal muscle phenotype also follows the same pattern, muscle strength, functionality, fCSA, capillarization, and SC, data were transformed into standardized scores (i.e. <italic toggle="yes">Z</italic>‐score), and then the RYGB + ET and RYGB groups were compared with controls. The RYGB + ET group and controls showed similar values in absolute and relative lower‐limb muscle strength and absolute upper‐limb muscle strength (<italic toggle="yes">P</italic> = 0.0531, <italic toggle="yes">P</italic> = 0.0620, <italic toggle="yes">P</italic> = 0.9999, respectively). In contrast, the RYGB group exhibited reduced values of absolute and relative lower‐limb muscle strength and absolute upper‐limb muscle strength vs. controls (<italic toggle="yes">P</italic> = 0.0002, <italic toggle="yes">P</italic> &lt; 0.0001, <italic toggle="yes">P</italic> = 0.0171, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panels C–F). The RYGB + ET group demonstrated even faster scores in the timed‐stand test than controls (<italic toggle="yes">P</italic> &lt; 0.0025), while the RYGB group showed slower scores than controls (<italic toggle="yes">P</italic> &lt; 0.0001). Both groups exhibited lower performance in the relative upper‐limb muscle strength test and timed‐up‐and‐go test as compared with controls (<italic toggle="yes">P</italic> &lt; 0.05 for all) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panels F and G, respectively).</p>
                <p>The RYGB + ET group also showed higher Types I and II fCSA, CC, and C/Fi, and comparable values of CFPE vs. controls (<italic toggle="yes">P</italic> = 0.0229 and <italic toggle="yes">P</italic> = 0.0038, <italic toggle="yes">P</italic> = 0.0080, <italic toggle="yes">P</italic> = 0.0143, and <italic toggle="yes">P</italic> = 0.9871, respectively). Conversely, the RYGB group had comparable type I and II fCSA, and lower values of CC, C/Fi, and CFPE <italic toggle="yes">vs</italic>. controls (<italic toggle="yes">P</italic> = 0.3341, <italic toggle="yes">P</italic> = 0.2975, <italic toggle="yes">P</italic> &lt; 0.0001, <italic toggle="yes">P</italic> = 0.0004, and <italic toggle="yes">P</italic> &lt; 0.0001, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panels I–M). Both groups showed lower SC content than controls (<italic toggle="yes">P</italic> = 0.0035 and <italic toggle="yes">P</italic> &lt; 0.0001, respectively) (<italic toggle="yes">Figure</italic>
<xref rid="jcsm12815-fig-0005" ref-type="fig">5</xref>, Panel N).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jcsm12815-sec-0025">
              <title>Discussion</title>
              <p>This trial demonstrated that a 6 month, three‐times‐a‐week, supervised exercise training programme attenuated the loss of fat‐free mass and reversed the loss of muscle strength among women who had bariatric surgery. The exercise training programme completely reversed surgery‐induced muscle fibre atrophy, and this was accompanied by increases in capillarization and satellite cell content. Interestingly, RNA‐seq and RT‐PCR analyses support the hypothesis that exercise suppressed the ubiquitin‐proteasome system, which may partially explain the beneficial effect of exercise on muscle remodelling. Of relevance, genotype and phenotype data revealed that skeletal muscle of patients who exercised resembled that of healthy lean individuals.</p>
              <p>Bariatric surgery is the treatment of choice for severe obesity, but this approach is not free of adverse effects. In consonance with previous studies,<xref rid="jcsm12815-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="jcsm12815-bib-0004" ref-type="bibr"><sup>4</sup></xref> we observed a drastic decrease in the absolute and relative lower‐limb and upper‐limb muscle strength 3 months following surgery, whereas no significant change was observed in functionality and relative strength. In contrast, the addition of a post‐surgery exercise training programme demonstrated to be an effective strategy to reverse the loss of absolute and relative lower‐limb muscle strength and relative upper‐limb muscle strength following surgery. It is noteworthy that exercised patients also increased absolute upper‐limb muscle strength following intervention, but it did not return to baseline values. Moreover, the combination of surgery plus exercise training provided improvements in functionality to a greater extent than that seen with surgery/standard of care 9 months following intervention. These data corroborate the hypothesis that exercise can offset the decline in muscle strength and function that is associated with bariatric surgery.<xref rid="jcsm12815-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref> Conversely, physical activity levels were unchanged in both groups throughout the study, supporting the idea that neither bariatric surgery nor structured exercise training are effective to promote profound increases in unstructured physical activity levels in this population.<xref rid="jcsm12815-bib-0035" ref-type="bibr"><sup>35</sup></xref>
</p>
              <p>Muscle atrophy and dysfunction following bariatric surgery is partially attributed to a substantial decrease in fat‐free mass.<xref rid="jcsm12815-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jcsm12815-bib-0018" ref-type="bibr"><sup>18</sup></xref> In agreement with previous studies, BMI, fat mass, total fat‐free mass, and lower‐limb and upper‐limb fat‐free mass were reduced at 3 and 9 months after surgery. While lifestyle interventions (e.g. exercise training and nutrition) are recommended to attenuate the loss of fat‐free mass among patients undergoing bariatric surgery,<xref rid="jcsm12815-bib-0036" ref-type="bibr"><sup>36</sup></xref>, <xref rid="jcsm12815-bib-0037" ref-type="bibr"><sup>37</sup></xref> efficacy is still debated.<xref rid="jcsm12815-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jcsm12815-bib-0018" ref-type="bibr"><sup>18</sup></xref> In this study, the losses in total and lower‐limb fat‐free mass were attenuated in the RYGB + ET in comparison with the RYGB group, supporting previous findings.<xref rid="jcsm12815-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jcsm12815-bib-0017" ref-type="bibr"><sup>17</sup></xref> Of note, the benefit of exercise on total and lower‐limb fat‐free mass was independent of the relatively low protein consumption reported by the patients (i.e. &lt;1 g·kg<sup>−1</sup>·day<sup>−1</sup>) (<italic toggle="yes">Table</italic>
<xref rid="jcsm12815-supitem-0001" ref-type="supplementary-material">S2</xref>), suggesting that exercise <italic toggle="yes">per se</italic> is an important anabolic stimulus for this population, although the between‐group differences for total and lower‐limb fat‐free mass were relatively small. Contrary to total and lower‐limb fat‐free mass data, exercise training was not able to mitigate upper‐limb fat‐free mass loss, despite the observed increase in upper‐limb muscle strength. A possible explanation may be related to the effects of aerobic exercise on muscle mass in untrained individuals.<xref rid="jcsm12815-bib-0038" ref-type="bibr"><sup>38</sup></xref> In this context, it is possible to speculate that the aerobic exercise (treadmill) may have provided an additional anabolic stimulus to the lower‐limb but not to the upper‐limb muscles, especially considering that patients still presented with high body mass values, even after surgery (BMI ~ 36 kg/m<sup>2</sup>). Gains in upper‐limb muscle strength may be linked to neural adaptations such as increase in the firing rate, inter‐ and intra‐ muscular coordination, motor unit synchronic improvement.<xref rid="jcsm12815-bib-0039" ref-type="bibr"><sup>39</sup></xref>
</p>
              <p>To further examine the effect of exercise on muscle remodelling at the muscle fibre level, we performed immunostaining assays from <italic toggle="yes">vastus lateralis</italic> samples. Our findings demonstrate a decrease in Type I and Type II fCSA 3 months following surgery in both groups. In contrast, the addition of a post‐surgery exercise training routine increased Type I and Type II fCSA when compared with the non‐exercised group. Furthermore, exercise was able to fully reverse the muscle fibre atrophy induced by surgery, as Types I and II fCSA were increased back to pre‐surgery levels in RYGB + ET group.</p>
              <p>Muscle fibre remodelling depends on the pool of satellite cells, which are localized between the basal lamina and sarcolemma. When activated, satellite cells proliferate and differentiate to supply additional myonuclei to the fibre or replenish the resident pool of satellite cells.<xref rid="jcsm12815-bib-0040" ref-type="bibr"><sup>40</sup></xref> We observed that exercise training increased the pool of satellite cells after the intervention, but muscle fibre myonuclei content remained unchanging, challenging the myonuclear domain hypothesis, according to which, during the hypertrophic process, myonuclei accretion is required to maintain a given surrounding territory of cytoplasm under the control of a given number of myonuclei. In another perspective, satellite cells are also thought to regulate fibrogenic cell collagen expression and, hence, muscle fibre extracellular matrix remodelling, another key factor related to muscle fibre remodelling.<xref rid="jcsm12815-bib-0041" ref-type="bibr"><sup>41</sup></xref> In this regard, we recently demonstrated that bariatric surgery decreased muscle extracellular matrix deposition, an effect that was potentiated by exercise.<xref rid="jcsm12815-bib-0025" ref-type="bibr"><sup>25</sup></xref> Taken together, these findings suggest that satellite cells may have been predominantly driven towards skeletal muscle extracellular matrix remodelling, rather than myonuclear accretion.</p>
              <p>The delivery of molecular signals [e.g. insulin‐like growth factor‐1 (IGF‐1), hepatocyte growth factor (HGF), interleukin‐6 (IL‐6) and myostatin] to skeletal muscle cells is highly dependent on muscle fibre capillarization, a key aspect in muscle remodelling.<xref rid="jcsm12815-bib-0042" ref-type="bibr"><sup>42</sup></xref> The formation of new capillaries in myofibres depends on a complex process termed angiogenesis, which is regulated by anti‐angiogenic and pro‐angiogenic factors. Our data indicate that exercise increased the expression of different angiogenesis markers (i.e. <italic toggle="yes">ANGP1</italic>, <italic toggle="yes">ANGP2</italic>, <italic toggle="yes">TEK</italic>, and <italic toggle="yes">VEGF</italic>), which was accompanied by increased muscle fibre capillarization. Collectively, these findings suggest that exercise increased muscle fibre perfusion via increased capillarization (mediated by alteration in the expression of numerous angiogenesis markers), possibly resulting in a more efficient delivery of oxygen, nutrients, and growth factors necessary for muscle fibre growth.</p>
              <p>To gather mechanistic insights on the effects of surgery combined with exercise on muscle remodelling‐related pathways, we performed RNA‐seq and RT‐PCR analysis of muscle samples that revealed that the <italic toggle="yes">ubiquitin‐mediated proteolysis</italic> pathway and <italic toggle="yes">Atrogin‐1</italic> gene expression was suppressed in the RYGB + ET group at POST9 vs. PRE, but not in the RYGB group. This suggests that exercise mitigated muscle protein breakdown mediated by the ubiquitin‐proteasome system and may represent an important part of the effect of exercise on muscle size.</p>
              <p>The autophagic system is responsible for removing and eliminating unfolded and toxic proteins as well as abnormal and dysfunctional organelles, through the formation of a double membrane vesicle that engulfs portion of the cytoplasm, organelles, glycogen, and protein aggregates, such as those that accumulate within the muscle cells of individuals with obesity.<xref rid="jcsm12815-bib-0043" ref-type="bibr"><sup>43</sup></xref> Of interest, we verified a decrease in the expression of autophagy system‐related genes (i.e. <italic toggle="yes">BNIP3</italic> and <italic toggle="yes">CTSL1</italic>) following surgery, which was not affected by exercise. These findings suggest that bariatric surgery induces a lower autophagic flux, possibly because of the substantial reduction in adiposity, which, in turn, may reduce the number of toxic proteins and dysfunctional organelles. This may represent a new mechanism associated with the beneficial effect of bariatric surgery on decreased systemic inflammation and endoplasmic reticulum stress.</p>
              <p><italic toggle="yes">mTOR</italic> pathway is recognized as a key regulator of muscle anabolism. Previous studies have shown that calorie restriction suppresses the expression of <italic toggle="yes">mTOR</italic> pathway‐related proteins,<xref rid="jcsm12815-bib-0044" ref-type="bibr"><sup>44</sup></xref> while mechanical stimuli are known to activate them.<xref rid="jcsm12815-bib-0045" ref-type="bibr"><sup>45</sup></xref> We were unable to identify significant changes in <italic toggle="yes">mTOR</italic> pathway‐related proteins (i.e. <italic toggle="yes">mTOR</italic> and <italic toggle="yes">P70S6K</italic>) as a result of surgery and exercise, with the exception of <italic toggle="yes">p‐4E‐BP1/4E‐BP1 that</italic> was reduced at POST9 and POST3 in comparison with baseline values. It is possible that the absence of change in these proteins was influenced by the timing of the muscle biopsy, because activation of these proteins appears to be dependent on an acute anabolic stimulus (e.g. protein ingestion or resistance exercise).<xref rid="jcsm12815-bib-0044" ref-type="bibr"><sup>44</sup></xref>, <xref rid="jcsm12815-bib-0046" ref-type="bibr"><sup>46</sup></xref> Therefore, caution should be exercised in concluding that exercise and surgery did not influence the <italic toggle="yes">mTOR</italic> pathway in this study.</p>
              <p>Muscle mass is regulated by the coordinated balance between the rates of muscle protein synthesis and muscle protein breakdown.<xref rid="jcsm12815-bib-0047" ref-type="bibr"><sup>47</sup></xref> Our findings suggest a complex network of mechanisms related to muscle fibre growth in patients with obesity undergoing bariatric surgery. Despite cellular adaptations occurring in the absence of chronic adaptations in proteins related to mTOR signalling pathway and in myonuclei content, exercise was shown to mitigate muscle protein breakdown, an observation that is supported by reduced gene expression in ubiquitin‐proteasome system related proteins. The increased muscle fibre capillarization and satellite cell content may also help explain our results, as these adaptations may have positively affected the spatial proximity between satellite cell and capillaries, facilitating the delivery of growth factors, thereby improving the myogenic response to exercise.<xref rid="jcsm12815-bib-0042" ref-type="bibr"><sup>42</sup></xref> Although it is reported that exercise increases myonuclei content during hypertrophy‐oriented conditions,<xref rid="jcsm12815-bib-0048" ref-type="bibr"><sup>48</sup></xref> our data suggest that the existing myonuclei in the exercised patients are capable of sustaining new transcriptional requirements of the muscle fibre in order to promote protein accretion under conditions that are unfavourable to hypertrophy (e.g. negative energy balance). It is difficult to put these novel data into perspective with the literature, as these are the first data to have assessed changes in fat‐free mass and histological and molecular parameters related to muscle fibre adaptations in obese patients undergoing bariatric surgery and exercise training.</p>
              <p>Obesity is associated with an abnormal gene expression profile<xref rid="jcsm12815-bib-0049" ref-type="bibr"><sup>49</sup></xref> and skeletal muscle phenotype.<xref rid="jcsm12815-bib-0050" ref-type="bibr"><sup>50</sup></xref> Furthermore, bariatric surgery can further aggravate muscle atrophy and strength loss. Within this scenario, we examined the extent to which exercise may rescue muscle genotype and phenotype in patients who underwent bariatric surgery comparing the experimental groups (i.e. RYGB + ET) and RYGB groups (at POST9) with a healthy lean group of reference. RYGB + ET showed a much lower number of differentially expressed genes when compared with healthy lean individuals than did RYGB (276 vs. 544 genes, respectively), and similar enrichment scores for all pathways analysed in the current study. In contrast, RYGB showed higher enrichment scores in the ubiquitin‐mediated proteolysis and FOXO signalling pathway which may negatively influence the chronic skeletal muscle adaptations. In agreement with the aforementioned results, RYGB + ET showed comparable values of absolute and relative lower‐limb muscle strength and absolute upper‐limb muscle strength with the healthy control group, while RYGB exhibited reduced values of absolute and relative lower‐limb muscle strength and absolute upper‐limb muscle strength. Taken together, our findings indicate that exercise following bariatric surgery can shift the skeletal muscle gene expression profile closer to what is expected for healthy lean individuals and, mostly important, that exercise training is effective in fully (e.g. muscle strength and muscle fibre capillarization) or partially (e.g. functionality) recovering some muscle phenotypical aspects that are negatively impacted by bariatric surgery. Nevertheless, caution should be exercised in the interpretations of these results, as our healthy lean control group was limited in size, which may be underpowered to detect statistically significant differences.</p>
              <p>The results of this study are not free of limitations. Our findings are confined to the main characteristics of the participants (i.e. middle‐aged women, with severe obesity, with a generally lower level of education, and economic status and limited by the duration of the follow‐up period.</p>
              <p>Despite excellent reliability scores, strength and functionality tests were performed by an unblinded investigator. Histological (i.e. cross‐sectional area of muscle fibres, satellite cells, and capillarization) and molecular (i.e. RNA‐seq, protein, and gene expression) analyses were performed in a sub‐sample of patients, and the experimental groups (RYGB and RYGB + ET at POST9) were compared with small sample of healthy lean control group, which may be underpowered for some measures.</p>
              <p>In conclusion, a 6 month, supervised training programme was an effective strategy to mitigate the commonly observed fat‐free mass loss and to reverse muscle atrophy and strength loss among women who had bariatric surgery, which may be partially explained by increases in capillarization, satellite cell content, and suppressed muscle protein breakdown mediated by ubiquitin‐proteasome system. Of relevance, exercise resulted in a skeletal muscle genotype and phenotype that more closely resembles that of healthy lean individuals. Collectively, this study provides evidence—from gene to function—that strongly supports the incorporation of exercise into the post‐operative routine of bariatric patients to counteract the adverse effects of surgery on muscle mass and function.</p>
            </sec>
            <sec id="jcsm12815-sec-0026">
              <title>Trial registration</title>
              <p>Clinicaltrial.gov: NCT02441361.</p>
            </sec>
            <sec sec-type="COI-statement" id="jcsm12815-sec-0028">
              <title>Conflict of interest</title>
              <p>The authors have declared that no conflict of interest exists.</p>
            </sec>
            <sec id="jcsm12815-sec-0027">
              <title>Funding</title>
              <p>The authors acknowledge the support by São Paulo Research Foundation (FAPESP—2016/10993‐5), the Brazilian National Council for Scientific and Technological Development (CNPq—grant 400157/2016‐0 and 301571/2017‐1). The study is also partially supported by NIGMS U54GM104940, and NIGMS P20GM103528 from NIH, USA, and by the National Medical Research Council and Ministry of Health, Singapore (WBS R913200076263). S.G., H.R. and B.G. are supported by grants from the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, 166622/202‐6; 488242/2018‐9; and 301914/2017‐6) B.G. and S.G. is also supported by a grant the Sao Paulo Research Foundation (FAPESP, 2017/13551‐2; 2020/08091‐9).</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="jcsm12815-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p><bold>Table S1.</bold> List of reagents and resources.</p>
                  <p><bold>Table S2.</bold> Dietary intake.</p>
                  <p><bold>Figure S1.</bold> Study Recruitment. RYGB+ET: Roux‐en‐Y Gastric Bypass plus Exercise Training group; RYGB: Roux‐en‐Y Gastric Bypass plus non‐exercise. ITT: intention‐to‐treat.</p>
                  <p><bold>Figure S2.</bold> Expression of Genes and Protein Related to Angiogenesis. RYGB+ET (<italic toggle="no">n</italic> = 14): Roux‐en‐Y Gastric Bypass plus Exercise Training group; RYGB (n = 14): Roux‐en‐Y Gastric Bypass plus non‐exercise. Gene expression of the <italic toggle="no">HIF1‐α</italic>, <italic toggle="no">ANGPT1</italic>, <italic toggle="no">ANGPT2</italic>, <italic toggle="no">MDM2</italic>, <italic toggle="no">TEK</italic> and <italic toggle="no">THSP1</italic> (Panel A, B, C, D, E and F, respectively). Protein expression of the <italic toggle="no">VEGF</italic> (Panel G). Representative image of the Western blot bands for <italic toggle="no">VEGF</italic> (Panel H). Data are expressed as mean ± SD. PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time; * indicates P &lt; 0.05 in comparison to PRE; # indicates P &lt; 0.05 in comparison to POST3; $ indicates P &lt; 0.05 for between‐group comparison at POST9.</p>
                  <p><bold>Figure S3.</bold> Expression of Genes and Proteins Related to Protein Breakdown mediated by Autophagic System. RYGB+ET (<italic toggle="no">n</italic> = 14[8 for western blot]): Roux‐en‐Y Gastric Bypass plus Exercise Training group; RYGB (n = 14[8 for western blot]): Roux‐en‐Y Gastric Bypass plus non‐exercise. Gene expression of the <italic toggle="no">BNIP3</italic>, <italic toggle="no">BECN1</italic> and <italic toggle="no">CTSL1</italic> (Panel A, B and C, respectively). Protein expression of the <italic toggle="no">Beclin‐1</italic> and <italic toggle="no">LC‐3</italic> (Panel D and E, respectively), Representative image of the Western blot bands for <italic toggle="no">Beclin‐1</italic> and <italic toggle="no">LC‐3</italic> (Panel H). Data are expressed as mean ± SD. PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time.</p>
                  <p><bold>Figure S4</bold>. Expression of Proteins Related to mTOR Pathway Along the Intervention Period. RYGB+ET (<italic toggle="no">n</italic> = 12): Roux‐en‐Y Gastric Bypass plus Exercise Training group; RYGB (n = 12): Roux‐en‐Y Gastric Bypass plus non‐exercise. Protein expression of the <italic toggle="no">p‐mTOR</italic>, <italic toggle="no">mTOR</italic>, <italic toggle="no">p‐mTOR/mTOR</italic> ratio (Panel A, B and C, respectively). Protein expression of the <italic toggle="no">p‐p70S6K</italic>, <italic toggle="no">p70S6K</italic>, <italic toggle="no">p‐p70S6K/p70S6K</italic> ratio (Panel D, E and F, respectively). Protein expression of the <italic toggle="no">p‐4E‐BP1</italic>, <italic toggle="no">4E‐BP1</italic>, <italic toggle="no">p‐4E‐BP1/4E‐BP1</italic> ratio (Panel G, H and I, respectively). Representative image of the Western blot of the proteins related to <italic toggle="no">mTOR</italic> pathway (Panel J). Data are expressed as mean ± SD. PRE: before surgery (baseline); POST3: 3 months following surgery; POST9: 9 months following surgery. ^ indicates <italic toggle="no">P</italic> &lt; 0.05 for main effect of time.</p>
                </caption>
                <media xlink:href="JCSM-12-1440-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list id="jcsm12815-bibl-0001" content-type="cited-references">
              <title>References</title>
              <ref id="jcsm12815-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0002"><string-name><surname>Schauer</surname><given-names>PR</given-names></string-name>, <string-name><surname>Bhatt</surname><given-names>DL</given-names></string-name>, <string-name><surname>Kirwan</surname><given-names>JP</given-names></string-name>, <string-name><surname>Wolski</surname><given-names>K</given-names></string-name>, <string-name><surname>Aminian</surname><given-names>A</given-names></string-name>, <string-name><surname>Brethauer</surname><given-names>SA</given-names></string-name>, et al. <article-title>Bariatric surgery versus intensive medical therapy for diabetes—5‐year outcomes</article-title>. <source>N Engl J Med</source><year>2017</year>;<volume>376</volume>:<fpage>641</fpage>–<lpage>651</lpage>.<pub-id pub-id-type="pmid">28199805</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0003"><string-name><surname>Coates</surname><given-names>PS</given-names></string-name>, <string-name><surname>Fernstrom</surname><given-names>JD</given-names></string-name>, <string-name><surname>Fernstrom</surname><given-names>MH</given-names></string-name>, <string-name><surname>Schauer</surname><given-names>PR</given-names></string-name>, <string-name><surname>Greenspan</surname><given-names>SL</given-names></string-name>. <article-title>Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass</article-title>. <source>J Clin Endocrinol Metab</source><year>2004</year>;<volume>89</volume>:<fpage>1061</fpage>–<lpage>1065</lpage>.<pub-id pub-id-type="pmid">15001587</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0004"><string-name><surname>Hue</surname><given-names>O</given-names></string-name>, <string-name><surname>Berrigan</surname><given-names>F</given-names></string-name>, <string-name><surname>Simoneau</surname><given-names>M</given-names></string-name>, <string-name><surname>Marcotte</surname><given-names>J</given-names></string-name>, <string-name><surname>Marceau</surname><given-names>P</given-names></string-name>, <string-name><surname>Marceau</surname><given-names>S</given-names></string-name>, et al. <article-title>Muscle force and force control after weight loss in obese and morbidly obese men</article-title>. <source>Obes Surg</source><year>2008</year>;<volume>18</volume>:<fpage>1112</fpage>–<lpage>1118</lpage>.<pub-id pub-id-type="pmid">18584262</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0005"><string-name><surname>Pereira</surname><given-names>AZ</given-names></string-name>, <string-name><surname>Marchini</surname><given-names>JS</given-names></string-name>, <string-name><surname>Carneiro</surname><given-names>G</given-names></string-name>, <string-name><surname>Arasaki</surname><given-names>CH</given-names></string-name>, <string-name><surname>Zanella</surname><given-names>MT</given-names></string-name>. <article-title>Lean and fat mass loss in obese patients before and after Roux‐en‐Y gastric bypass: a new application for ultrasound technique</article-title>. <source>Obes Surg</source><year>2012</year>;<volume>22</volume>:<fpage>597</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">22065342</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0006"><string-name><surname>Brandt</surname><given-names>C</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>BK</given-names></string-name>. <article-title>The role of exercise‐induced myokines in muscle homeostasis and the defense against chronic diseases</article-title>. <source>J Biomed Biotechnol</source><year>2010</year>;<volume>2010</volume>:<elocation-id>520258</elocation-id>.<pub-id pub-id-type="pmid">20224659</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0007"><string-name><surname>Egan</surname><given-names>B</given-names></string-name>, <string-name><surname>Zierath</surname><given-names>JR</given-names></string-name>. <article-title>Exercise metabolism and the molecular regulation of skeletal muscle adaptation</article-title>. <source>Cell Metab</source><year>2013</year>;<volume>17</volume>:<fpage>162</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">23395166</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0008"><string-name><surname>Lightfoot</surname><given-names>A</given-names></string-name>, <string-name><surname>McArdle</surname><given-names>A</given-names></string-name>, <string-name><surname>Griffiths</surname><given-names>RD</given-names></string-name>. <article-title>Muscle in defense</article-title>. <source>Crit Care Med</source><year>2009</year>;<volume>37</volume>:<fpage>S384</fpage>–<lpage>S390</lpage>.<pub-id pub-id-type="pmid">20046124</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0009"><string-name><surname>Chung</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Wu</surname><given-names>C</given-names></string-name>, <string-name><surname>Jones</surname><given-names>M</given-names></string-name>, <string-name><surname>Kato</surname><given-names>TS</given-names></string-name>, <string-name><surname>Dam</surname><given-names>TT</given-names></string-name>, <string-name><surname>Givens</surname><given-names>RC</given-names></string-name>, et al. <article-title>Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement</article-title>. <source>J Card Fail</source><year>2014</year>;<volume>20</volume>:<fpage>310</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">24569037</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0010"><string-name><surname>Rantanen</surname><given-names>T</given-names></string-name>, <string-name><surname>Harris</surname><given-names>T</given-names></string-name>, <string-name><surname>Leveille</surname><given-names>SG</given-names></string-name>, <string-name><surname>Visser</surname><given-names>M</given-names></string-name>, <string-name><surname>Foley</surname><given-names>D</given-names></string-name>, <string-name><surname>Masaki</surname><given-names>K</given-names></string-name>, et al. <article-title>Muscle strength and body mass index as long‐term predictors of mortality in initially healthy men</article-title>. <source>J Gerontol A Biol Sci Med Sci</source><year>2000</year>;<volume>55</volume>:<fpage>M168</fpage>–<lpage>M173</lpage>.<pub-id pub-id-type="pmid">10795731</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0011"><string-name><surname>Rantanen</surname><given-names>T</given-names></string-name>, <string-name><surname>Volpato</surname><given-names>S</given-names></string-name>, <string-name><surname>Ferrucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Heikkinen</surname><given-names>E</given-names></string-name>, <string-name><surname>Fried</surname><given-names>LP</given-names></string-name>, <string-name><surname>Guralnik</surname><given-names>JM</given-names></string-name>. <article-title>Handgrip strength and cause‐specific and total mortality in older disabled women: exploring the mechanism</article-title>. <source>J Am Geriatr Soc</source><year>2003</year>;<volume>51</volume>:<fpage>636</fpage>–<lpage>641</lpage>.<pub-id pub-id-type="pmid">12752838</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0012"><string-name><surname>Beals</surname><given-names>JW</given-names></string-name>, <string-name><surname>Burd</surname><given-names>NA</given-names></string-name>, <string-name><surname>Moore</surname><given-names>DR</given-names></string-name>, <string-name><surname>van Vliet</surname><given-names>S</given-names></string-name>. <article-title>Obesity Alters the Muscle Protein Synthetic Response to Nutrition and Exercise</article-title>. <source>Front Nutr</source><year>2019</year>;<volume>6</volume>:<fpage>87</fpage>.<pub-id pub-id-type="pmid">31263701</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0013"><string-name><surname>Beals</surname><given-names>JW</given-names></string-name>, <string-name><surname>Skinner</surname><given-names>SK</given-names></string-name>, <string-name><surname>McKenna</surname><given-names>CF</given-names></string-name>, <string-name><surname>Poozhikunnel</surname><given-names>EG</given-names></string-name>, <string-name><surname>Farooqi</surname><given-names>SA</given-names></string-name>, <string-name><surname>van Vliet</surname><given-names>S</given-names></string-name>, et al. <article-title>Altered anabolic signalling and reduced stimulation of myofibrillar protein synthesis after feeding and resistance exercise in people with obesity</article-title>. <source>J Physiol</source><year>2018</year>;<volume>596</volume>:<fpage>5119</fpage>–<lpage>5133</lpage>.<pub-id pub-id-type="pmid">30113718</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0014"><string-name><surname>Bollinger</surname><given-names>LM</given-names></string-name>, <string-name><surname>Powell</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Houmard</surname><given-names>JA</given-names></string-name>, <string-name><surname>Witczak</surname><given-names>CA</given-names></string-name>, <string-name><surname>Brault</surname><given-names>JJ</given-names></string-name>. <article-title>Skeletal muscle myotubes in severe obesity exhibit altered ubiquitin‐proteasome and autophagic/lysosomal proteolytic flux</article-title>. <source>Obesity (Silver Spring)</source><year>2015</year>;<volume>23</volume>:<fpage>1185</fpage>–<lpage>1193</lpage>.<pub-id pub-id-type="pmid">26010327</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0015"><string-name><surname>Frisbee</surname><given-names>JC</given-names></string-name>. <article-title>Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats</article-title>. <source>Am J Physiol Heart Circ Physiol</source><year>2003</year>;<volume>285</volume>:<fpage>H104</fpage>–<lpage>H111</lpage>.<pub-id pub-id-type="pmid">12649071</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0016"><string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Foretz</surname><given-names>M</given-names></string-name>, <string-name><surname>Viollet</surname><given-names>B</given-names></string-name>, <string-name><surname>Du</surname><given-names>M</given-names></string-name>. <article-title>Obesity impairs skeletal muscle regeneration through inhibition of AMPK</article-title>. <source>Diabetes</source><year>2016</year>;<volume>65</volume>:<fpage>188</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">26384382</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0017"><string-name><surname>Campanha‐Versiani</surname><given-names>L</given-names></string-name>, <string-name><surname>Pereira</surname><given-names>DAG</given-names></string-name>, <string-name><surname>Ribeiro‐Samora</surname><given-names>GA</given-names></string-name>, <string-name><surname>Ramos</surname><given-names>AV</given-names></string-name>, <string-name><surname>de Sander Diniz</surname><given-names>MFH</given-names></string-name>, <string-name><surname>De Marco</surname><given-names>LA</given-names></string-name>, et al. <article-title>The effect of a muscle weight‐bearing and aerobic exercise program on the body composition, muscular strength, biochemical markers, and bone mass of obese patients who have undergone gastric bypass surgery</article-title>. <source>Obes Surg</source><year>2017</year>;<volume>27</volume>:<fpage>2129</fpage>–<lpage>2137</lpage>.<pub-id pub-id-type="pmid">28285470</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0018"><string-name><surname>Herring</surname><given-names>LY</given-names></string-name>, <string-name><surname>Stevinson</surname><given-names>C</given-names></string-name>, <string-name><surname>Carter</surname><given-names>P</given-names></string-name>, <string-name><surname>Biddle</surname><given-names>SJH</given-names></string-name>, <string-name><surname>Bowrey</surname><given-names>D</given-names></string-name>, <string-name><surname>Sutton</surname><given-names>C</given-names></string-name>, et al. <article-title>The effects of supervised exercise training 12–24 months after bariatric surgery on physical function and body composition: a randomised controlled trial</article-title>. <source>Int J Obes (Lond)</source><year>2017</year>;<volume>41</volume>:<fpage>909</fpage>–<lpage>916</lpage>.<pub-id pub-id-type="pmid">28262676</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0019"><string-name><surname>Stegen</surname><given-names>S</given-names></string-name>, <string-name><surname>Derave</surname><given-names>W</given-names></string-name>, <string-name><surname>Calders</surname><given-names>P</given-names></string-name>, <string-name><surname>Van Laethem</surname><given-names>C</given-names></string-name>, <string-name><surname>Pattyn</surname><given-names>P</given-names></string-name>. <article-title>Physical fitness in morbidly obese patients: effect of gastric bypass surgery and exercise training</article-title>. <source>Obes Surg</source><year>2011</year>;<volume>21</volume>:<fpage>61</fpage>–<lpage>70</lpage>.<pub-id pub-id-type="pmid">19997987</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0020"><string-name><surname>Daniels</surname><given-names>P</given-names></string-name>, <string-name><surname>Burns</surname><given-names>RD</given-names></string-name>, <string-name><surname>Brusseau</surname><given-names>TA</given-names></string-name>, <string-name><surname>Hall</surname><given-names>MS</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>L</given-names></string-name>, <string-name><surname>Adams</surname><given-names>TD</given-names></string-name>, et al. <article-title>Effect of a randomised 12‐week resistance training programme on muscular strength, cross‐sectional area and muscle quality in women having undergone Roux‐en‐Y gastric bypass</article-title>. <source>J Sports Sci</source><year>2018</year>;<volume>36</volume>:<fpage>529</fpage>–<lpage>535</lpage>.<pub-id pub-id-type="pmid">28467737</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0021"><string-name><surname>Coppini</surname><given-names>LZ</given-names></string-name>, <string-name><surname>Waitzberg</surname><given-names>DL</given-names></string-name>, <string-name><surname>Campos</surname><given-names>AC</given-names></string-name>. <article-title>Limitations and validation of bioelectrical impedance analysis in morbidly obese patients</article-title>. <source>Curr Opin Clin Nutr Metab Care</source><year>2005</year>;<volume>8</volume>:<fpage>329</fpage>–<lpage>332</lpage>.<pub-id pub-id-type="pmid">15809537</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0022"><string-name><surname>Dantas</surname><given-names>WS</given-names></string-name>, <string-name><surname>Gil</surname><given-names>S</given-names></string-name>, <string-name><surname>Murai</surname><given-names>IH</given-names></string-name>, <string-name><surname>Costa‐Hong</surname><given-names>V</given-names></string-name>, <string-name><surname>Pecanha</surname><given-names>T</given-names></string-name>, <string-name><surname>Merege‐Filho</surname><given-names>CAA</given-names></string-name>, et al. <article-title>Reversal of improved endothelial function after bariatric surgery is mitigated by exercise training</article-title>. <source>J Am Coll Cardiol</source><year>2018</year>;<volume>72</volume>:<fpage>2278</fpage>–<lpage>2279</lpage>.<pub-id pub-id-type="pmid">30360835</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0023"><string-name><surname>Murai</surname><given-names>IH</given-names></string-name>, <string-name><surname>Roschel</surname><given-names>H</given-names></string-name>, <string-name><surname>Dantas</surname><given-names>WS</given-names></string-name>, <string-name><surname>Gil</surname><given-names>S</given-names></string-name>, <string-name><surname>Merege‐Filho</surname><given-names>C</given-names></string-name>, <string-name><surname>de Cleva</surname><given-names>R</given-names></string-name>, et al. <article-title>Exercise mitigates bone loss in women with severe obesity after roux‐en‐y gastric bypass: a randomized controlled trial</article-title>. <source>J Clin Endocrinol Metab</source><year>2019</year>;<volume>104</volume>:<fpage>4639</fpage>–<lpage>4650</lpage>.<pub-id pub-id-type="pmid">31322672</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0024"><string-name><surname>Coen</surname><given-names>PM</given-names></string-name>, <string-name><surname>Menshikova</surname><given-names>EV</given-names></string-name>, <string-name><surname>Distefano</surname><given-names>G</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>D</given-names></string-name>, <string-name><surname>Tanner</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Standley</surname><given-names>RA</given-names></string-name>, et al. <article-title>Exercise and weight loss improve muscle mitochondrial respiration, lipid partitioning, and insulin sensitivity after gastric bypass surgery</article-title>. <source>Diabetes</source><year>2015</year>;<volume>64</volume>:<fpage>3737</fpage>–<lpage>3750</lpage>.<pub-id pub-id-type="pmid">26293505</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0025"><string-name><surname>Coen</surname><given-names>PM</given-names></string-name>, <string-name><surname>Tanner</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Helbling</surname><given-names>NL</given-names></string-name>, <string-name><surname>Dubis</surname><given-names>GS</given-names></string-name>, <string-name><surname>Hames</surname><given-names>KC</given-names></string-name>, <string-name><surname>Xie</surname><given-names>H</given-names></string-name>, et al. <article-title>Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity</article-title>. <source>J Clin Invest</source><year>2015</year>;<volume>125</volume>:<fpage>248</fpage>–<lpage>257</lpage>.<pub-id pub-id-type="pmid">25437877</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0026"><string-name><surname>Dantas</surname><given-names>WS</given-names></string-name>, <string-name><surname>Roschel</surname><given-names>H</given-names></string-name>, <string-name><surname>Murai</surname><given-names>IH</given-names></string-name>, <string-name><surname>Gil</surname><given-names>S</given-names></string-name>, <string-name><surname>Davuluri</surname><given-names>G</given-names></string-name>, <string-name><surname>Axelrod</surname><given-names>CL</given-names></string-name>, et al. <article-title>Exercise‐induced increases in insulin sensitivity after bariatric surgery are mediated by muscle extracellular matrix remodeling</article-title>. <source>Diabetes</source><year>2020</year>;<volume>69</volume>:<fpage>1675</fpage>–<lpage>1691</lpage>.<pub-id pub-id-type="pmid">32409493</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0027"><string-name><surname>Freedson</surname><given-names>PS</given-names></string-name>, <string-name><surname>Melanson</surname><given-names>E</given-names></string-name>, <string-name><surname>Sirard</surname><given-names>J</given-names></string-name>. <article-title>Calibration of the Computer Science and Applications, Inc accelerometer</article-title>. <source>Med Sci Sports Exerc</source><year>1998</year>;<volume>30</volume>:<fpage>777</fpage>–<lpage>781</lpage>.<pub-id pub-id-type="pmid">9588623</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0028"><string-name><surname>Mackey</surname><given-names>AL</given-names></string-name>, <string-name><surname>Kjaer</surname><given-names>M</given-names></string-name>, <string-name><surname>Charifi</surname><given-names>N</given-names></string-name>, <string-name><surname>Henriksson</surname><given-names>J</given-names></string-name>, <string-name><surname>Bojsen‐Moller</surname><given-names>J</given-names></string-name>, <string-name><surname>Holm</surname><given-names>L</given-names></string-name>, et al. <article-title>Assessment of satellite cell number and activity status in human skeletal muscle biopsies</article-title>. <source>Muscle Nerve</source><year>2009</year>;<volume>40</volume>:<fpage>455</fpage>–<lpage>465</lpage>.<pub-id pub-id-type="pmid">19705426</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0029"><string-name><surname>Hepple</surname><given-names>RT</given-names></string-name>. <article-title>A new measurement of tissue capillarity: the capillary‐to‐fibre perimeter exchange index</article-title>. <source>Can J Appl Physiol</source><year>1997</year>;<volume>22</volume>:<fpage>11</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">9018404</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="miscellaneous" id="jcsm12815-cit-0030"><collab collab-type="authors">Team RDC</collab>
. <article-title>A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical computing</article-title>. Retrieved from <ext-link xlink:href="http://www.R-project.org" ext-link-type="uri">http://www.R‐project.org</ext-link>. <year>2010</year>. <ext-link xlink:href="https://4.bp.blogspot.com/-9IgLQzbLJA0/T8FKI_BXerI/AAAAAAAAA8Q/qnoKvinVzvE/s1600/20120106_endnote_2.png" ext-link-type="uri">https://4.bp.blogspot.com/‐9IgLQzbLJA0/T8FKI_BXerI/AAAAAAAAA8Q/qnoKvinVzvE/s1600/20120106_endnote_2.png</ext-link>
</mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0031"><string-name><surname>Robinson</surname><given-names>MD</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name>. <article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source><year>2010</year>;<volume>26</volume>:<fpage>139</fpage>–<lpage>140</lpage>.<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0032"><string-name><surname>Law</surname><given-names>CW</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Shi</surname><given-names>W</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name>. <article-title>voom: precision weights unlock linear model analysis tools for RNA‐seq read counts</article-title>. <source>Genome Biol</source><year>2014</year>;<volume>15</volume>:<fpage>R29</fpage>.<pub-id pub-id-type="pmid">24485249</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0033"><string-name><surname>Livak</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Schmittgen</surname><given-names>TD</given-names></string-name>. <article-title>Analysis of relative gene expression data using real‐time quantitative PCR and the 2(‐delta delta C(T)) method</article-title>. <source>Methods</source><year>2001</year>;<volume>25</volume>:<fpage>402</fpage>–<lpage>408</lpage>.<pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0034"><string-name><surname>Axelrod</surname><given-names>CL</given-names></string-name>, <string-name><surname>Fealy</surname><given-names>CE</given-names></string-name>, <string-name><surname>Mulya</surname><given-names>A</given-names></string-name>, <string-name><surname>Kirwan</surname><given-names>JP</given-names></string-name>. <article-title>Exercise training remodels human skeletal muscle mitochondrial fission and fusion machinery towards a pro‐elongation phenotype</article-title>. <source>Acta Physiol (Oxf)</source><year>2019</year>;<volume>225</volume>:<elocation-id>e13216</elocation-id>.<pub-id pub-id-type="pmid">30408342</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0035"><string-name><surname>Romero‐Calvo</surname><given-names>I</given-names></string-name>, <string-name><surname>Ocon</surname><given-names>B</given-names></string-name>, <string-name><surname>Martinez‐Moya</surname><given-names>P</given-names></string-name>, <string-name><surname>Suarez</surname><given-names>MD</given-names></string-name>, <string-name><surname>Zarzuelo</surname><given-names>A</given-names></string-name>, <string-name><surname>Martinez‐Augustin</surname><given-names>O</given-names></string-name>, et al. <article-title>Reversible Ponceau staining as a loading control alternative to actin in Western blots</article-title>. <source>Anal Biochem</source><year>2010</year>;<volume>401</volume>:<fpage>318</fpage>–<lpage>320</lpage>.<pub-id pub-id-type="pmid">20206115</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0036"><string-name><surname>Chapman</surname><given-names>N</given-names></string-name>, <string-name><surname>Hill</surname><given-names>K</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>S</given-names></string-name>, <string-name><surname>Hassanali</surname><given-names>M</given-names></string-name>, <string-name><surname>Straker</surname><given-names>L</given-names></string-name>, <string-name><surname>Hamdorf</surname><given-names>J</given-names></string-name>. <article-title>Patterns of physical activity and sedentary behavior after bariatric surgery: an observational study</article-title>. <source>Surg Obes Relat Dis</source><year>2014</year>;<volume>10</volume>:<fpage>524</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">24462340</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0037"><string-name><surname>Mingrone</surname><given-names>G</given-names></string-name>, <string-name><surname>Bornstein</surname><given-names>S</given-names></string-name>, <string-name><surname>Le Roux</surname><given-names>CW</given-names></string-name>. <article-title>Optimisation of follow‐up after metabolic surgery</article-title>. <source>Lancet Diab Endocrinol</source><year>2018</year>;<volume>6</volume>:<fpage>487</fpage>–<lpage>499</lpage>.</mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0038"><string-name><surname>Mechanick</surname><given-names>JI</given-names></string-name>, <string-name><surname>Youdim</surname><given-names>A</given-names></string-name>, <string-name><surname>Jones</surname><given-names>DB</given-names></string-name>, <string-name><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name><surname>Hurley</surname><given-names>DL</given-names></string-name>, <string-name><surname>McMahon</surname><given-names>MM</given-names></string-name>, et al. <article-title>Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic &amp; Bariatric Surgery</article-title>. <source>Obesity (Silver Spring)</source><year>2013</year>;<volume>21</volume>:<fpage>S1</fpage>–<lpage>S27</lpage>.<pub-id pub-id-type="pmid">23529939</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0039"><string-name><surname>Konopka</surname><given-names>AR</given-names></string-name>, <string-name><surname>Harber</surname><given-names>MP</given-names></string-name>. <article-title>Skeletal muscle hypertrophy after aerobic exercise training</article-title>. <source>Exerc Sport Sci Rev</source><year>2014</year>;<volume>42</volume>:<fpage>53</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">24508740</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0040"><string-name><surname>Moritani</surname><given-names>T</given-names></string-name>, <string-name><surname>de Vries</surname><given-names>HA</given-names></string-name>. <article-title>Neural factors versus hypertrophy in the time course of muscle strength gain</article-title>. <source>Am J Phys Med</source><year>1979</year>;<volume>58</volume>:<fpage>115</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">453338</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0041"><string-name><surname>Yin</surname><given-names>H</given-names></string-name>, <string-name><surname>Price</surname><given-names>F</given-names></string-name>, <string-name><surname>Rudnicki</surname><given-names>MA</given-names></string-name>. <article-title>Satellite cells and the muscle stem cell niche</article-title>. <source>Physiol Rev</source><year>2013</year>;<volume>93</volume>:<fpage>23</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">23303905</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0042"><string-name><surname>Fry</surname><given-names>CS</given-names></string-name>, <string-name><surname>Kirby</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Kosmac</surname><given-names>K</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>CA</given-names></string-name>. <article-title>Myogenic Progenitor Cells Control Extracellular Matrix Production by Fibroblasts during Skeletal Muscle Hypertrophy</article-title>. <source>Cell Stem Cell</source><year>2017</year>;<volume>20</volume>:<fpage>56</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">27840022</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0043"><string-name><surname>Joanisse</surname><given-names>S</given-names></string-name>, <string-name><surname>Nederveen</surname><given-names>JP</given-names></string-name>, <string-name><surname>Snijders</surname><given-names>T</given-names></string-name>, <string-name><surname>McKay</surname><given-names>BR</given-names></string-name>, <string-name><surname>Parise</surname><given-names>G</given-names></string-name>. <article-title>Skeletal muscle regeneration, repair and remodelling in aging: the importance of muscle stem cells and vascularization</article-title>. <source>Gerontology</source><year>2017</year>;<volume>63</volume>:<fpage>91</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">27760421</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0044"><string-name><surname>Jamart</surname><given-names>C</given-names></string-name>, <string-name><surname>Benoit</surname><given-names>N</given-names></string-name>, <string-name><surname>Raymackers</surname><given-names>JM</given-names></string-name>, <string-name><surname>Kim</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Kim</surname><given-names>CK</given-names></string-name>, <string-name><surname>Francaux</surname><given-names>M</given-names></string-name>. <article-title>Autophagy‐related and autophagy‐regulatory genes are induced in human muscle after ultraendurance exercise</article-title>. <source>Eur J Appl Physiol</source><year>2012</year>;<volume>112</volume>:<fpage>3173</fpage>–<lpage>3177</lpage>.<pub-id pub-id-type="pmid">22194006</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0045"><string-name><surname>Chen</surname><given-names>CN</given-names></string-name>, <string-name><surname>Liao</surname><given-names>YH</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>SC</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>LV</given-names></string-name>. <article-title>Age‐dependent effects of caloric restriction on mTOR and ubiquitin‐proteasome pathways in skeletal muscles</article-title>. <source>GeroScience</source><year>2019</year>;<volume>41</volume>:<fpage>871</fpage>–<lpage>880</lpage>.<pub-id pub-id-type="pmid">31676964</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0046"><string-name><surname>Bolster</surname><given-names>DR</given-names></string-name>, <string-name><surname>Kubica</surname><given-names>N</given-names></string-name>, <string-name><surname>Crozier</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Williamson</surname><given-names>DL</given-names></string-name>, <string-name><surname>Farrell</surname><given-names>PA</given-names></string-name>, <string-name><surname>Kimball</surname><given-names>SR</given-names></string-name>, et al. <article-title>Immediate response of mammalian target of rapamycin (mTOR)‐mediated signalling following acute resistance exercise in rat skeletal muscle</article-title>. <source>J Physiol</source><year>2003</year>;<volume>553</volume>:<fpage>213</fpage>–<lpage>220</lpage>.<pub-id pub-id-type="pmid">12937293</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0047"><string-name><surname>Bolster</surname><given-names>DR</given-names></string-name>, <string-name><surname>Kimball</surname><given-names>SR</given-names></string-name>, <string-name><surname>Jefferson</surname><given-names>LS</given-names></string-name>. <article-title>Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy</article-title>. <source>Exerc Sport Sci Rev</source><year>2003</year>;<volume>31</volume>:<fpage>111</fpage>–<lpage>116</lpage>.<pub-id pub-id-type="pmid">12882475</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0048"><string-name><surname>Phillips</surname><given-names>SM</given-names></string-name>. <article-title>A brief review of critical processes in exercise‐induced muscular hypertrophy</article-title>. <source>Sports Med</source><year>2014</year>;<volume>44</volume>:<fpage>S71</fpage>–<lpage>S77</lpage>.<pub-id pub-id-type="pmid">24791918</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0049"><string-name><surname>Allen</surname><given-names>DL</given-names></string-name>, <string-name><surname>Monke</surname><given-names>SR</given-names></string-name>, <string-name><surname>Talmadge</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Roy</surname><given-names>RR</given-names></string-name>, <string-name><surname>Edgerton</surname><given-names>VR</given-names></string-name>. <article-title>Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers</article-title>. <source>J Appl Physiol</source><year>1995</year>;<volume>78</volume>:<fpage>1969</fpage>–<lpage>1976</lpage>.<pub-id pub-id-type="pmid">7649936</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0050"><string-name><surname>Messaoudi</surname><given-names>I</given-names></string-name>, <string-name><surname>Handu</surname><given-names>M</given-names></string-name>, <string-name><surname>Rais</surname><given-names>M</given-names></string-name>, <string-name><surname>Sureshchandra</surname><given-names>S</given-names></string-name>, <string-name><surname>Park</surname><given-names>BS</given-names></string-name>, <string-name><surname>Fei</surname><given-names>SS</given-names></string-name>, et al. <article-title>Long‐lasting effect of obesity on skeletal muscle transcriptome</article-title>. <source>BMC Genomics</source><year>2017</year>;<volume>18</volume>:<fpage>411</fpage>.<pub-id pub-id-type="pmid">28545403</pub-id></mixed-citation>
              </ref>
              <ref id="jcsm12815-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="journal" id="jcsm12815-cit-0051"><string-name><surname>Coen</surname><given-names>PM</given-names></string-name>, <string-name><surname>Hames</surname><given-names>KC</given-names></string-name>, <string-name><surname>Leachman</surname><given-names>EM</given-names></string-name>, <string-name><surname>DeLany</surname><given-names>JP</given-names></string-name>, <string-name><surname>Ritov</surname><given-names>VB</given-names></string-name>, <string-name><surname>Menshikova</surname><given-names>EV</given-names></string-name>, et al. <article-title>Reduced skeletal muscle oxidative capacity and elevated ceramide but not diacylglycerol content in severe obesity</article-title>. <source>Obesity (Silver Spring)</source><year>2013</year>;<volume>21</volume>:<fpage>2362</fpage>–<lpage>2371</lpage>.<pub-id pub-id-type="pmid">23512750</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
